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1CHAPTER I
Introduction
In 2003, one in eight children in Maryland was born prematurely (March of
Dimes, 2004).  This high incidence is accompanied by an increased likelihood for these
children to demonstrate developmental disabilities (Linden, Paroli, & Doran, 2000).
Neonatal Intensive Care Unit (NICU) Follow-Up programs aim to identify children, born
prematurely, who may be developmentally delayed; however, these programs lack valid
screening measures to help do this effectively.  The need for new valid screening tools is
influenced by theory and driven by public policy (McLean, Bailey, & Wolery, 1996).
The Maryland Developmental Screen (MDS) is a new screening tool, designed to screen
the developmental status of children.  Prior to this study, the MDS had not been subjected
to validation procedures.  The purpose of this first validation study was to determine the
concurrent validity of the MDS when compared to the Bayley Scales of Infant
Development, Second Edition (BSID-II) with a population of infants and toddlers who
were born prematurely.
Although there has been no reduction in the incidence of prematurity, the
mortality rate for children born prematurely has been reduced by half within the past 15
years (Hall, 2000).  Despite the reduction in mortality, morbidity related to premature
birth remains high.  Approximately 11% of pregnancies result in premature births and
these births are responsible for 70% of neonatal deaths and 50% of all neonatal
disabilities.   In the United States, an average of 6,040 children are born at a low birth
weight (less than 2,500 grams) and 1,126 are born at a very low birth weight (less than
1,500 grams) each week (March of Dimes, 2004).  Currently, the survival rate for infants
2born at 23 weeks gestation is 20%, at 25 weeks gestation it is 65%, and between 26 and
33 weeks the survival rate ranges from 75% to 95% (Linden, et al., 2000).  Of the 61.3%
families that reported the ethnicity of their children who were born prematurely in
Maryland between 2000 and 2002, the rates were as follows: 16.9% African American,
12.0% Native American, 11.7%, Hispanic, 10.8% Caucasian and 9.9% Asian (March of
Dimes, 2004).
Although the survival rate has increased dramatically during the last two decades,
a substantial body of research suggests that, despite advances in neonatal intensive care,
infants who are born at a low birth weight (less than 2,500 grams) are at high risk for
mental and physical disabilities (Berger, Holt-Turner, Cuppoli, Mass, & Hagerman,
1998; Linden et al., 2000; Resnick, Eyler, Nelson, Eitzman, & Bucciarelli, 1997).  A
lower birth weight (less than 1,500 grams) is related to a higher risk for developing future
disabilities (McGrath, Sullivan, Lester, & Oh, 2000).  Disabilities associated with
premature birth vary and include cerebral palsy, language delays, and poor intellectual
and neuromotor development, which often result in behavioral difficulties at school age
(Nadeau, Boibin, Tessier, Lefebvre, & Robaey, 2001; McGrath, et al., 2000).  According
to Linden and her colleagues (2000), mild to severe disabilities occur with 66% of infants
born between 23 and 25 weeks gestation, 60% of infants born between 26 and 29 weeks
gestation, and 35% of infants between 30 and 33 weeks gestation.
Due to the risk of developmental delay demonstrated by infants born prematurely,
it is important, especially within the first three years of life, to frequently screen and
assess their developmental status. Screening, operationally defined as a “brief assessment
designed to identify children who should receive more intensive diagnosis or assessment”
3(Meisels & Provence, 1989, p. 58), is often used to examine large numbers of children in
a cost- and time-efficient manner.  Through the screening of a child’s developmental
status, appropriate anticipatory guidance may be provided to the family.  The provision of
anticipatory guidance involves informing caregivers about what a child is expected to do
next as well as providing them with activities to help facilitate development.  Subsequent
assessment following the screening may also lead to referral to early intervention
programs. The rationale for providing screening of infants born prematurely is grounded
in developmental theory and is reflected in public policy.
Theoretical Frameworks
The theory which grounds developmental screening of infants and toddlers is
reflected in many different disciplines, including special education, developmental
psychology and behavioral pediatrics (McLean et al., 1996). These theories provide a
basis for design, methods, and the subsequent validity of developmental screening
instruments that are used. According to the maturationist theory, developmental screening
and assessment of all children relies on an assumption that development occurs on a
predictable continuum (Shonkoff & Meisels, 2000). The constructivist theory views
children as active participants in the learning process (Shonkoff & Meisels, 2000).  These
two theoretical frameworks guided the prominent contributing perspectives of Als (Als,
1986; Als, Lester, Tronick, & Brazelton, 1982), Brazelton (1973), Gesell (1949) and
Piaget (1952) in the assumption that child development is hierarchical and dependent on
the environment.
Focusing on the neonatal period, Als and her colleagues’ (1982) synactive model
of development suggest that development occurs in a hierarchy of developing subsystems
4of overall organization.  These subsystems include motor (e.g., tone, movement, activity,
posture), autonomic (e.g., skin color, tremors/startles, heart rate), states (e.g.,
sleepy/drowsy, awake/alert), attention/interaction (e.g., alertness) and self-regulatory
(e.g., infants’ ability to balance other subsystems) (LaRossa, 2002). Each of the five
subsystems is dependent upon on one another and upon continuous interaction with the
environment (LaRossa, 2000; McLean et al., 1996). LaRossa (2002), suggests that infants
who are born prematurely typically have disorganized subsystems and are more
dependent on the environment than infants who are full term and healthy. As a child
grows, the subsystems mature, become more organized, and begin to promote one
another (LaRossa, 2002).  Brazelton’s (1973) organismic view of infant development also
suggests that infants’ responses lead to and become a background for the subsequent
levels of development. Like Als (1986), Brazelton’s framework views an infant as an
active contributor to development as demonstrated through his or her behavioral
organization. (McLean et al., 1996).
Within the field of behavioral pediatrics, Arnold Gesell’s (1949) theory of
developmental schedules suggests that early development is maturational and that the
environment determines the occasion, intensity and correlation of many behaviors
(McLean, et al., 1996).  The progression of development is inherently related to age-
sequence development and this sequence of schedules is the most important indicator of a
child’s development.  Many screening and assessment instruments, including the BSID-II
(Bayley, 1993) and the Denver II (Frankenburg, Dodds, Archer, Shapiro, & Bresnick,
1992) have theoretical underpinnings based on Gesell’s concept of developmental
schedules (McLean et al., 1996).
5Piaget (1952) theorizes that development occurs in a hierarchical series of stages.
Each stage evolves from a preceding one, and no stage can be skipped (Sattler, 1992).
An infant’s sensorimotor organizational schemas, defined as interrelated memories,
thoughts, and strategies that a child uses, change and mature with the assimilation and
acquisition of new information (McLean et al., 1996).   Screening instruments and
assessments which draw upon a Piagetian approach are constructed according to age
levels with item clusters that attempt to measure multiple aspects of development
(McLean et al., 1996).  The Piagetian approach to developmental screening and
assessment is particularly reflected in the measurement of specific domains of cognitive
development, including spatial concepts, object permanence, deductive and inductive
logic, classification and decentration. Along with the theories of Als, Brazelton, and
Gesell, Piaget’s theory has influenced public policy that currently provides the delivery
of early intervention services.
Policies and Mandates Required for Screening
The importance of developmental screening for infants and toddlers is reflected in
federal legislation and is considered to be an integral part of the Child Find efforts. Part C
of Public Law (P.L.) 99-457 of IDEA established Child Find for infants and toddlers in
1986. The Child Find effort requires that states identify all children eligible for education,
health and social service programs (McLean et al., 1996). This mandate continues under
the reauthorization of IDEA, P.L. 105-17, enacted in 1997.  If a child is identified as
eligible, then provisions, mandated by each state, are provided.  In addition to the Child
Find efforts, the most recent reauthorization of IDEA (2004) brought changes in Section
637 of Part C.  This section states that every child involved with a substantiated case of
6child abuse or neglect, as well as any child who is identified as affected by illegal
substance abuse or withdrawal symptoms resulting from prenatal drug exposure, must
also be developmentally screened to determine whether a referral for an evaluation under
Part C is warranted.
In addition to Part C of IDEA, Early Head Start requires developmental screening
within 45 days of a child’s entry into the program (45 CFR 1304.20).  The federal Early
Periodic Screening, Diagnosis, and Treatment (EPSDT) program, based upon a model of
preventative care for early detection of illness and developmental problems, also
recommends routine developmental screening during well-child visits (Hess, Papas, &
Black, 2004; Rosenbach & Gavin, 1998).  Finally, the American Academy of Pediatrics
(AAP) policy statement reflects the need for developmental screening, recommending
that all infants and young children be screened for developmental delay at health
supervision visits (Committee on Children with Disabilities, 2001). In addition to this
policy statement, the AAP recommends that neurodevelopmental follow-up occur for all
infants born prematurely (Committee on Children with Disabilities, 2001).
Importance of Validity
The effective implementation of public policies requiring the screening of infants
and toddlers necessitates empirical evidence to assure that screening instruments used are
valid. Validity refers to appropriateness of inferences that are made based on specific test
results (Salvia and Ysseldyke, 2001.)  One way in which an instrument’s validity is
demonstrated is through criterion validity.  Criterion validity is an indicator of an
instrument’s accuracy in estimating performance on a widely accepted criterion measure
(Salvia & Ysseldyke, 2001).  Criterion validity research must include the following: (a)
7an accurate description and rationale for use of the criterion measure, (b) a description of
the sample and statistical analysis used, and (c) limits of generalizability of validity
information (Salvia & Ysseldyke, 2001).  It is also important to consider the
consequential validity of screening tools (Messick, 1986).  This concept is related to
evidence of an instrument’s actual and potential outcomes including value judgements,
social implications, and political consequence (Humphries-Wadsworth, 1998).
The Problem
Neonatal Intensive Care Unit (NICU) follow-up programs are designed to provide
ongoing screening and assessment of the growth and development of high-risk and
moderate-risk infants discharged from the NICU.  Once children are identified through
such programs, early intervention services can be implemented. These programs do not
typically replace traditional pediatric care; their purpose, rather, is specifically related to
the identification of medical and developmental problems (Hussey-Gardner, Wachtel, &
Viscardi, 1998). Many NICU follow-up programs (e.g., UMMS) use screening measures
to determine whether or not a child’s development may be delayed and therefore require
in-depth evaluation. Existing screening instruments examine a child’s developmental
status through parent report, direct administration by a professional, or a combination of
parent report and direct administration.  The review of literature presented in Chapter II
suggests that there are currently no published fully validated screening instruments that
enable staff of NICU follow-up clinics to adequately measure the developmental status of
infants born prematurely. At first glance, 12 screening instruments appeared to be capable
of effectively screening for potential developmental delays of infants born prematurely.
These instruments include:
8 Ages and Stages Questionnaire (ASQ) (Squires, Bricker, & Potter, 1997),
 Healthy Steps “Quick Check Sheets” (Healthy Steps, 1996),
  Behavioral Assessment of Baby’s Emotional and Social Style (BABES)
(Finello, 1994),
 Child Development Inventories (CDI) (Ireton, 1992),
 Early Intervention Developmental Profile (EIDP) (Rogers, D’Eugenio,
Brown, Donovan, & Lynch, 1981),
 Brigance Screen (Brigance, 1990),
  Brigance Infant Toddler Screen (BITS),
 Diagnostic Inventory for Screening Children (DISC) (Amdur, Mainland, &
Parker, 1990),
 Battelle Developmental Inventory Screening Test (Newborg, Stock, Wnek,
Guidubaldi, & Svinicki, 1998),
 Bayley Infant Neurodevelopmental Screen (BINS) (Alyward, 1995),
 Parent’s Evaluation of Developmental Status (PEDS) (Ellsworth &
Vandermeer, 1997),
 and the Denver Developmental Screen-II (Frankenburg, Dodds, Archer,
Bresnick, Maschka, Edelman, & Shapiro, 1992).
However, none of these instruments best meet the needs for screening infants and
toddlers born prematurely.  Prior to this study, there was no established method to
evaluate instruments designed to screen the development of infants and toddlers born
prematurely. Based upon child development theory, and empirical and clinical evidence
(Committee on Children with Disabilities, 2001; Glascoe et al, 1992; McLean et al.,
91996; Sonnader, 2000), the researcher identified the following criteria for NICU follow-
up programs to most effectively screen children born prematurely (see Chapter II for
further discussion):
1. developmental screening of all six developmental domains (namely cognitive,
language, social-emotional, adaptive, gross motor, and fine motor),
2. use of minimal materials,
3. ease and speed of administration,
4. ability to test young infants with an adjusted age of less than term,
5. hands-on assessment,
6. parent involvement in the assessment process,
7. professional evaluation of the quality of the child’s performance,
8. validity of screening.
Children should be screened in the six developmental domains so that the
appropriate discipline (e.g., a speech and language therapist for a child with a language
delay) may conduct a more in-depth assessment when needed.  A screening instrument
should be able to be administered with minimal materials and there should be ease and
speed in administration so that clinic staff can easily screen many children in a NICU
follow-up program’s quick paced environment.  Due to their degree of prematurity,
children may attend an initial NICU follow-up program appointment prior to an adjusted
age of full term (< 40 weeks gestation); a screening instrument should have the ability to
assess development even at this point.  Since hands-on assessment is a requirement of
neonatology training programs, a screening instrument must have the capacity for
administrators to observe and examine the children in addition to gaining information
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from parent report. The requirement of parent involvement in the screening process is
mandated in the federal legislation’s Part C of P. L. 105-17 of IDEA (Part C – Individuals
with Disabilities).   In addition, professional evaluation of the quality of a child’s
performance should be provided. For example, if a child’s gross motor development is
age appropriate but he drags his left foot, the screening instrument should provide an
opportunity for recording such a concern so that the child will optimally receive needed
early intervention services.  This is necessary because there is an atypical eligibility
criterion for early intervention services and clinicians must have the tools to assist in the
identification of this type of development. Finally, a screening instrument is only useful if
it demonstrates validity (Committee on Children with Disabilities, 2001).
An in-depth analysis of the 12 instruments suggests that there is no measure that
adequately meets each and every criterion and thereby meets the needs of a NICU follow-
up program.  Measures including the ASQ and the CDI fail to examine very young
infants. An example of why this presents a problem is demonstrated with a child who was
born 12 weeks early and is screened at three months of age.  With an adjustment for
prematurity, such a child should be tested at 40 weeks gestation, or at birth.  Even at this
early age, it is possible to gain pertinent developmental information regarding children;
however, test items must be available to examine issues such as quality of tone and
reflexes.  Although the Denver II and other screening instruments do provide test items
for children at birth, no information is obtained regarding the quality of performance
observed.  This issue also presents problems with parent report screening measures in
which no professional observation of the child is conducted. Another problem is that
results of studies also indicate that sensitivity and specificity rates of less than the
11
recommended 70% and 70-80% respectively (Sonnader 2000) have been found with
screening measures including the Denver II, CDI and Brigance Screens (Byrne, Ashford,
Johnson, Chang, & Strickland, 1992; Glascoe, 2002; Glascoe, Shoemaker et al., 1993).
The MDS, developed in 2001, attempts to meet the screening needs of children
born prematurely (See Appendix A).  This instrument’s 161 items assess the six domains
of cognition, language, social-emotional, adaptive, gross-motor and fine motor
development of children whose adjusted ages range from 30 weeks post-conceptual age
through 39 months of age.  It does so in a manner that is quick and easy, uses minimal
materials, and uses information gathered by both hands-on assessment and parent
involvement in the assessment process.  Although currently in use in one NICU follow-
up program, prior to this study the MDS had not yet undergone validity procedures.
Purpose and Objectives
An examination of currently available screening instruments suggests that there is
no published tool that adequately assesses the developmental status of infants born
prematurely. Although one instrument, the MDS, appears to meet this unmet need, it had
yet to be subjected to rigorous validation procedures. The purpose of this study was to
determine the concurrent validity of the MDS when compared to the “gold standard”
(Sattler, 1992, p. 321) of developmental assessments, the Bayley Scales of Infant
Development, Second Edition (BSID-II).  To address this issue the following research
questions were asked:
12
1. What is the sensitivity of the MDS when concurrently administered with the
BSID-II?
2. What is the specificity of the MDS when concurrently administered with the
BSID-II?
3. What is the overall hit rate and chance hit rate of the MDS when compared to
the BSID-II?
13
CHAPTER II
Review of Literature
This chapter presents a review of the literature in three important areas and then
describes the MDS and its application.  This chapter will provide an understanding of the
developmental and medical outcomes of children born prematurely.  The function of
Neonatal Intensive Care (NICU) follow up programs that often monitor the progress of
these children is also described.  Developmental screening of infants and toddlers,
including a critical examination of published screening tools, is presented. Finally, a
description of the Maryland Developmental Screen (MDS) and the instrument’s
application will be provided.
Outcomes of Children Born Prematurely
While the survival rate for children born prematurely has dramatically increased
within the last 30 years, longitudinal studies suggest that those children who are born at a
very low birth weight (less than 1,500 grams) and extremely low birth weight (less than
1,000 grams) are more prone to developmental delay (McGrath et al., 2000; Nadeau et
al., 2001; Perlman, 2001). Medical complications due to low birth weight may impact
later development.  Complications may include underdevelopment of the lungs, digestive
system and nervous system; more specifically, these infants are at risk for necrotizing
enterocolitis, intraventicular hemorrhage, respiratory distress syndrome,
broncopulmonary dysplasia, patent ductus arteriosis, and periventricular leukomalacia
(Bernbaum & Batshaw, 1997; Subramanian, Yoon, & Troal, 2002). Neurodevelopmental,
intellectual, motor, and language outcome have been demonstrated to be negatively
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associated with low birth weight (McGrath et al., 2000; Nadeau et al., 2001; Singer,
Siegal, Lewis, Hawkins, Yamashita, & Baley, 2001).
There has been a growing body of longitudinal research related to the
developmental outcomes of infants born prematurely (Hack, Taylor, Klein, Eiben,
Schatschneider & Mercuric-Minich, 1994; McGrath et al., 2000; Nadeau et al., 2001;
Singer et al., 20001; Vorh, 2000).  Perlman (2001) found that large number of infants
born prematurely exhibit neurobehavioral problems, even in the absence of cerebral
palsy.  Approximately 30% to 50% of children born prematurely demonstrate below
average academic achievement, 20% to 30% are affected by attention
deficit/hyperactivity disorder, and approximately 25% to 30% demonstrate psychiatric
disorders during adolescence (Perlman, 2001).  Perlman (2001) attributes these
neurobehavioral problems to an inherent vulnerability of a prematurely developed brain
during a critical period of development, the multiple clinical problems which are specific
to prematurity, and the stressful environmental conditions in which a premature infant is
placed.
Similarly, researchers suggest that behavioral problems at school age may be
related to the influence of prematurity on neuromotor functioning (Nadeau et al., 2001;
McGrath et al., 2000).  Neurodevelopmental deficits demonstrated by children born
prematurely are often manifested in the form of behavioral problems and academic
difficulties.  Nadeau and others’ (2001) research with 61 very low birth weight (VLBW)
and 44 normal birth weight children found that elementary school children, between five
and nine years of age who were born at VLBW were at significantly increased risk for
neurological problems (33%) compared to children born at a normal birth weight (3%).
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Parents and teachers observed that VLBW children have more internalized and
externalized problems than their peers who were born at a normal weight.  The
internalized problems included more social withdrawal and sadness.  External problems
cited were hyperactivity, inattentiveness, and aggressiveness.  Peers of the children with
VLBW also evaluated them to be more sensitive and hyperactive than children born at a
normal birth weight.  Results of this study provide evidence that preterm birth is
associated with intellectual and neuromotor delays and that these deficits account for the
predictive relationship between premature birth and behavioral problems (Nadeau et al.,
2001).   
McGrath and others (2000) also studied neurological functioning with a sample
(N = 188) of children who were born at full term, healthy preterm, clinically ill, and
neurologically compromised.  The sample of children was assessed at 18 and 30 months
and at four and eight years of age.  The methodological procedures conducted involved
repeated neurological categorization and developmental assessment of cognition,
academic performance, socioeconomic status (SES), and medical status.  Similar to the
work of others (Perlman, 2000; Nadeau et al., 2001), findings of this study suggest that
the change in neurologic classification over time varies as a function of neonatal
morbidity, and the changes identified also affect cognitive and school achievement
outcomes.  McGrath and others (2000) indicate that this study extends the research by
identifying neurological examination throughout childhood as a marker for long-term
outcomes of NICU survivors.
Longitudinal research of infants born prematurely conducted by Singer and others
(2001) has focused on language development.  These researchers found that 20%-40% of
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VLBW survivors are considered language delayed or impaired as toddlers and young
children. The researchers (Singer et al., 2001) conducted a prospective study of infants
born at VLBW with and without bronchopulmonary dysplasia (BPD) and of infants born
at full term to examine speech and language development and specific language
impairments at three years of age.  Findings suggest that infants born at VLBW with a
history of BPD have lower receptive and language skills than infants born at a VLBW
with no history of BPD and than those born at full term.  A surprising result of this study
was that the presence of patent ductus arteriosis (PDA) was the best predictor of language
deficits, and when the occurrence of PDA and BPD were combined, there were
differentially lower language scores (Singer et al., 2001).
Prematurity and Socioeconomic Status (SES)
The development of a child born prematurely is likely to be complicated,
particularly as that child matures, by environmental risk factors such as low SES, low
maternal age, and teenage parenting factors (Hess, Papas, & Black, 2004; Leonard et al.,
2001). Researchers have examined longitudinal developmental outcomes of infants born
prematurely in relation to how the environment impacts development (Hack et al., 1994;
Singer et al., 2001; Weisglas-Kuperus, Baerts, Smrkovsky, & Sauer, 1993). Singer et al.
(2001) indicate that neurological complications, low socioeconomic status, and minority
race (not specified) were significant predictors of language delay.  They caution,
however, that it is important to consider both medical and SES factors when evaluating
the risk of infants born at VLBW for poorer speech language outcomes (Singer, et al.,
2001).  Hack and his colleagues (1994) similarly suggest that although developmental
outcomes appear to be more closely associated with neonatal complications than social
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disadvantage, both should be considered.  The research conducted by Weisglas-Kuperus
and her colleagues (1993) also examined the relationship of sociodemographic variables,
social stimulation and cognitive development on infants ages 1 through 3.6 years who
were born at a VLBW.  Neurological scores obtained through the Kaufman Assessment
Battery (Melchers & Preuss, 1991) predicted infant development in the first year of life;
from two years of age, however, a combination of biological and home environment
factors influenced child development. Environmental factors become more significant as
a child matures, but biological factors, such as prematurity, may be more important in
predicting the first two years of a child’s development (Hess et al., 2004).
NICU Follow-Up
Findings within the literature suggest that when children who were born
prematurely are discharged from the NICU they remain at risk for future developmental
disabilities (Montgomery, 1999; Bull, Bryson, Schreiner, & Lemons, 1986).  This risk
necessitates systematic monitoring, follow-up, and early intervention services.  The intent
of a NICU follow-up clinic is to provide “ongoing evaluation of growth and development
of high risk and moderate risk infants discharged from the NICU” (Hussey-Gardner,
1995, p. 33).  Rather than replace routine pediatric care, NICU follow-up clinics should
provide examinations and testing designed to recognize early developmental and medical
problems (Hussey-Gardner, 1995). NICU follow-up programs are designed to provide a
coordinated effort of identification, evaluation, and service delivery to infants.  A
recommended best practice of care for these infants involves the collaboration of neonatal
intensive care unit staff, early intervention providers, and outpatient NICU follow-up
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staff in order to ensure appropriate referral and expedient delivery of early intervention
services (Hussey-Gardner, McNinch, Anastasi, & Miller, 2002).
Developmental Screening
Developmental screening is defined as “a brief assessment designed to identify
children who should receive more intensive diagnosis or assessment” (Meisels &
Provence, 1989, p. 58).  Screening may result in the assessment of a child’s
developmental status and subsequently lead to referral to early intervention programs.
Screening is based upon a framework of typical development in which a child’s
achievements are placed upon a continuum of normal accomplishments (Shonkoff &
Meisels, 2000). Assessment differs from screening because it involves a more in-depth
collaborative process of ongoing, systematic observations and analysis (Greenspan &
Meisels, 1996).
Age Adjustment.  An adjustment of age to account for a child’s prematurity is
often calculated prior to conducting developmental screening and/or assessment.  This
adjustment allows for a more accurate comparison of the developmental status of children
born prematurely with children who are born at full term (Brenbaum & Batshaw, 1997).
When using the child’s chronological age rather than an adjusted age, studies have found
that achievement of developmental milestones occurs significantly later than with
children who are born at full term (Matilainen, 1987).   There is, however, disagreement
and inconclusive research regarding at which age this adjustment should be discontinued
(Brenbaum & Batshaw, 1997; Rickards, Kitchen, Doyle, & Kelly, 1989; Wilson &
Michaeleen, 2004).  According to Bernbaum and Batshaw (1997), the classic approach to
age adjustment is to continue do so until the child is two years of age, thereby presuming
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that by this age he or she has caught up with children of the same age who were born at
full term.  However, as infants mature, a complete age adjustment may lead to an
overestimation of a child’s development status (Wilson & Michaeleen, 2004).  Because
there is no empirical consensus as to the age at which the adjustment should stop,
programs often set their own criteria.  For example, at the University of Maryland’s
NICU Follow-Up Clinic, the age when the adjustment is stopped is when the child’s
adjusted age is one year old.
 The process of screening infants and young children is often the first experience
that a family has with early intervention and frequently also serves as a therapeutic
experience in itself (McLean, et al., 1996).  According to Harris and Daniels (2001), most
pediatric developmental screening tests are designed with the intent of differentiating
children who are suspected of having a developmental concern from those who appear to
be developing normally.  A screening instrument enables evaluators to cast a wide net to
select children who may need closer monitoring as well as serving as a formal indicator
of present developmental status and need for timely early intervention services (Harris &
Daniels, 2001; Leonard, Piecuch, & Cooper, 2001; Sonnader, 2000).
Researchers recommend that developmental screening be in the form of a brief
evaluation, intended to identify children with suspected problems who are in need of
more complete diagnostic assessment (Doig, Macia, Conway, Craver, & Ingram, 1999).
Criteria for evaluating screening tests should include an examination of the variables of
acceptability, simplicity, cost appropriateness, and reliability and validity (Harris &
Daniels, 2001).  The use of a screening tool must be acceptable to the family whose child
is being screened, to the professionals who administer it, and to the community in which
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it is used.  Additionally, it should be relatively simple in terms of training and
administration.
Doig and colleagues (1999) stress that repeated screening is necessary because
both the biological and environmental risk factors that affect development can change
over time.  A single test at one point in time provides a snapshot of a child’s
developmental process; periodic screening is necessary to detect emerging delays as a
child grows (Committee on Children with Disabilities, 2001).  Screening in the first year
of life, particularly with an infant born prematurely, can be problematic.  Complications
may include transient muscle tone differences that may present as a delay and often
resolve by the first year.  Furthermore, children born at a low birth weight have increased
medical risk factors such as asphyxia and maternal substance abuse, as well as increased
social risk factors including low SES, low maternal age, and teenage parenting (Leonard
et al., 2001).
Subspecialty pediatric clinics, as well as general pediatrician offices, utilize
screening instruments and developmental assessments to monitor the development of
children.  When pediatricians and other health care providers use only their clinical
judgment rather than formal screening and assessment procedures, estimates of a child’s
development may be less accurate than when a more objective instrument is used
(Committee on Children with Disabilities, 2001).  Limited time and low reimbursement
rates, however, hamper the use of developmental screening and assessments (Doig et al.,
1999).  Use of formal screening in pediatric practice is also limited by lack of consensus
on what is suitable for screening general populations, what is easily integrated into the
practice protocol, and what is cost efficient (Dobrez, Sasso, Holl, Shalowitz, Leon, &
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Budetti 2001).  Screening instruments are designed to obtain information on a child’s
developmental status using questionnaires provided to the parents, through administration
of test items by professionals, and through recording observations of children.
Sensitivity and Specificity
A screening instrument’s level of sensitivity and specificity should be examined
when considering use.  An instrument’s sensitivity is related to how accurately children
with developmental delays are identified and the specificity refers to the accuracy in
identifying those children without disabilities (Sonnader, 2000).  The evaluation of an
instrument’s levels of sensitivity and specificity is important in determining cutoff scores
for making referrals for further assessment, which may consequently lead to the
acquisition of early intervention services (McLean et al., 1996).   For example, in
Maryland, one way that a child is determined to be eligible for early intervention services
is if he or she demonstrates a 25 % delay in one or more developmental areas. The levels
of sensitivity and specificity of a particular screening instrument are, therefore, vital in
making decisions regarding which children should receive in-depth assessment to
determine whether they are deemed eligible for services.   According to Sonnader (2000),
a level of 70% for sensitivity and a level of 70-80% for specificity are acceptable
percentages for developmental screening instruments.
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Screening Instruments
Accurate developmental screening of infants and toddlers contributes to parental
well-being and assists in appropriately allocating limited diagnostic and health care
services (Glascoe, Byrne, Ashford, Johnson, Chang, & Strickland, 1992). Early
childhood screening also serves as a reminder to professionals to observe a child’s
development and provides an efficient method to record clinical observations (Committee
on Children with Disabilities, 2001). Most importantly, however, screening ensures that
children who are in need of early intervention due to the presence of a developmental
delay are identified as early as possible (Committee on Children with Disabilities, 2001;
Glascoe et al., 1992; McLean et al., 1996; Sonnader, 2000).
Although at first glance there may appear to be a plethora of screening
instruments widely available to determine the developmental status of infants and young
children born prematurely, a closer look at the literature yields few viable instruments.
The literature was reviewed to determine whether there were any existing screening tools
that adequately meet the needs of a NICU follow-up program. The criteria upon which
each tool was evaluated presented in Figure 1 included: (a) developmental screening of
all six developmental domains (namely cognitive, language, social-emotional, adaptive,
gross motor, and fine motor), (b) use of minimal materials,  (c) ease and speed in
administration, (d) ability to test young infants with an adjusted age of less than term, (e)
hands-on assessment, (f) parent involvement in the assessment process, (g) professional
evaluation of the quality of a child’s performance, and (h) validity of the test.
Furthermore, the technical adequacy of instruments considered for the use with infants
born prematurely was explored.
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Figure 1
Criteria for Developmental Screening of Infants and Toddlers Born Prematurely
Professionals have accomplished the screening of infants and young children
through direct administration of test items, parent report of child development, and a
combination of administration and parent report.   Instruments attempting to screen only a
child’s global development were omitted from this review.  A rationale for the decision to
omit instruments that approach developmental screening through examination of global
development, such as the Vineland Social Maturity (Doll, 1953), is provided by Katoff
and Reuter (1980).  These authors suggest that the separation of items into developmental
domains has value that is prescriptive, diagnostic and predictive.  Whereas a typically
developing infant generally exhibits uniformity across all domains of growth, an infant
who is delayed may demonstrate unique patterns and inconsistencies.  Screening
instruments that provide only global scores or fail to separate development into domains
consequently fail to yield adequate information to indicate the direction of further
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24
assessment and intervention.  Furthermore, these are instruments not particularly useful
in providing feedback to parents (Katoff & Reuter, 1980).  Also omitted were instruments
that screen one domain only.  These instruments were not included as they do not provide
information across domains.  Domain specific instruments omitted include the Cognitive
Adaptive Test and Clinical Linguistic and Auditory Milestone Scales (CAT/CLAMS)
(Capute & Accardo, 1996) and the Peabody Developmental Motor Scales (Folio &
Fewell, 2000).
 Screening measures that exclusively examine neonatal neuromotor function were
additionally excluded from this review.   Instruments examining this newborn period are
not typically designed to assess the development of older infants and toddlers.  These
instruments, including the Brazelton Neonatal Behavioral Assessment Scale (Brazelton,
1973), the Carey Temperament Scales (Carey, 2002), and the Harris Infant Neuromotor
Test (Harris & Daniels, 2001) focus on normal qualitative behavioral variations and are
not designed to be used to screens for early identification of developmental or behavioral
abnormalities (Carey, 2002).   Rather, the general purpose of such neonatal measures is to
demonstrate an infant’s “capacities for using his or her inner organization to experience,
integrate, and profit developmentally from developmental stimulation” (Brazelton, 1994,
p. 289).
Professionals have accomplished the screening of infants and young children
through direct administration of test items, parent report of child development, and a
combination of administration and parent report.   Table 1 provides an overview of
screening tools included in this review. An overview of studies examined, including
statistical indices, is provided in Table 2.
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Table 1
Screening Tools
Tool Authors Ages Method Areas Assessed
Ages & Stages
Questionnaire (ASQ)
Bricker &
Squires (1997)
4 months
to 5 years
Parent
report
Communication, gross motor,
fine motor, problem solving,
personal-social
Behavioral Assessment of
Baby’s Emotional &
Social Style (BABES)
Finello (1994) High-risk
infants
Parent
report
Temperament, ability to self-
soothe, regulatory processes
Battelle Developmental
Screening Test
Newborg, Stock,
Wnek,
Guidubaldi, &
Svinicki (1988)
Birth to
8 years
Direct &
parent
report
Gross motor, fine motor,
psychosocial, adaptive
expressive language, receptive
language, cognitive
Bayley Infant
Neurodevelopmental
Screen (BINS)
Alyward (1995) Birth to
42
months
Direct &
parent
report
Neurological processes,
neurodevelopmental skills,
developmental
accomplishments
Brigance Infant Toddler
Screen (BITS)
Brigance &
Glascoe (2002)
Birth to 2
years
Direct Fine motor, receptive language,
expressive language, gross
motor, self-help, social-
emotional
Brigance Brigance (1990) 21 to 36
months
Direct Fine motor, receptive language,
expressive language, gross
motor, self-help, social-
emotional
Child Developmental
Inventories (CDI, formerly
Minnesota Developmental
Inventories)
Ireton (1992) 15
months to
6 years
Parent
report
Social, self-help, motor,
language, letter and number
skills, presence of symptoms
and behavior problems
Denver II Frankenburg et
al, (1992)
Birth to 6
years
Direct &
parent
report
Gross motor, fine
motor/adaptive, language,
personal-social
26
Table 1: Screening Tools continued
Tool Authors Ages Method Areas Assessed
Diagnostic
Inventory for
Screening
Children, 3rd
Edition (DISC)
Amdur, Mainland, &
Parker (1990)
Birth to
5 years
Direct Expressive language, receptive
language, gross motor, fine
motor, psychosocial, self-help
Early
Intervention
Developmental
Profile (EIDP)
Rogers, D’Eugenio,
Brown, Donovan, &
Lynch (1981)
Birth to
36
months
Direct Perception/fine motor,
cognition, language, social-
emotional, self-care, gross
motor
Parents
Evaluation of
Developmental
Status (PEDS)
Ellsworth & Vandermeer
Press, Ltd. (1997)
Birth to
8 years
Parent
report
Cognition, expressive language
and articulation, receptive
language, fine motor, gross
motor, behavior, social self-
help, school skills
Quick Check
Sheets
Healthy Steps (1996) Birth to
3 years
Parent
report
Developmental areas, parent-
child interactions, parenting
concerns
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Table 2
Overview of Selected Studies
Tool Study Authors Comparison
Criteria
N Indices
ASQ Squires, Bricker,
& Potter, 1997
standardized
measures
7,000 Specificity: high across questionnaire
intervals
Sensitivity: lower, varied across
questionnaire intervals
Concurrent validity: 85% (range of
76% to 91%)
BINS Leonard, Piecuch,
& Cooper, 2001
BSID-II (MDI &
PDI)
133 Association: MDI r = .4
PDI r = .35
Predictive validity: 67-76%
BINS Hess, Papas, &
Black, 2004
BSID-II (MDI &
PDI)
106 6 & 13 month BINS scores used to
predict BSID-II at 24 months: low
sensitivity values, high specificity
values
CDI Shoemaker,
Saylor, &
Erickson, 1993
BSID-II (MDI) 280 Concurrent validity: .39 to .53 for all
scales
Specificity: 92%
Sensitivity: 56%
CDI Kopparthi,
McDermott,
Sheftel, Lenke,
Getz, & Frey,
1991
BSID-II (MDI &
PDI)
101 Correlation: strong correlation by
domain
CDI Diog, Macias,
Saylor, Craver, &
Ingram, 1999
CAT/CLAMS
BSID-II
73 Correlation: CAT/CLAMS r = .87
BSID-II r = .86
Specificity: 94-96%
Sensitivity: 80-100%
CDI Montgomery,
1999
CAT/CLAMS
Slosson
Intelligence Test
76 Specificity: 87%
Sensitivity: 73%
CDI Saylor & Brant,
1986
BSID-II 115 Correlation: .75 - .91
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Table 2: Overview of Selected Studies continued
Tool Study
Authors
Comparison
Criteria
N Indices
Denver II Glascoe,
Byrne,
Ashford,
Johnson,
Chang, &
Strickland,
1992
BSID-II
Kaufman
Assessment Battery
for Children,
Stanford-Binet 4th
ed.,
Vineland Adaptive
Behavior Scale
104 Specificity: 43%
Sensitivity: 83%
DISC Schwarting,
1998
other screening
tests & criterion
measures
*
Validity: Good content and face
Reliability: Adequate
BITS Glascoe, 2002 BSID –II, REEL,
Preschool
Language Scale,
Rosetti, Vineland,
Alberta Infant
Motor Scale
408
Specificity: 86%
Sensitivity: 77%
Battelle Glascoe &
Byrne, 1993
intelligence,
adaptive, language,
and achievement
measures
104
Specificity: 73%
Sensitivity: 75%
Battelle Ikle &
Wittmer, 1995
Vineland
BSID-II
Denver II
Validity: High
Evidence of over-referral compared
to Denver II
* Unavailable
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Parent Report
The design of screening instruments that utilize parent report to determine the
developmental status of infants and young children varies from checklists of questions
asked by professionals to questionnaires that are completed by the parents.  Parent report
instruments are traditionally attributed with good psychometric properties and, because
they are quick to administer, are often employed in pediatric offices (Committee on
Children with Disabilities, 2001).  Published screening instruments that elicit
developmental information via parent report include the Ages and Stages Questionnaire
(ASQ), the Healthy Steps “Quick Check Sheets”, the Behavioral Assessment of Baby’s
Emotional and Social Style (BABES), and the Child Development Inventories (CDI).
Questionnaires, such as the ASQ, provide directions for parents to indicate their
child’s skills.  Although questionnaires are often cost effective and take little time from
the professional, concerns related to length of the questionnaire and accuracy of parental
response should be considered.  Researchers in one study suggest that questionnaires that
are provided to caretakers yield a low return, as one-third of their sample was compliant
(Doig et al., 1999).
Ages and Stages Questionnaire (ASQ). The ASQ is a screening instrument that
focuses on children from four months through five years of age.  Drawings and directions
are provided to parents so that they can indicate their child’s skills.  Parents complete a
30-item questionnaire given at 11 different intervals based on their child’s chronological
age (4, 6, 8, 12, 16, 18, 20, 24, 30, 36, and 48 months of age).  Each questionnaire probes
parents on information related to the five developmental areas of gross motor, fine motor,
communication, cognition, and personal-social development (McLean et al., 1997).
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Included are questions geared to assess neurological reflexes (e.g., reflexes and tone),
neurodevelopmental skills (e.g., movement and symmetry), and developmental
accomplishments (e.g., object permanence, imitation, and language) (Dobrez et al.,
2001). Items are scored by a check of “yes”, “sometimes”, or “not yet”, and in turn are
given a numeric value.   Within each domain the numeric score is compared with cutoff
scores found within the manual and if the child’s score is below the cut-off, more in-
depth assessment is recommended.
Squires, Bricker and Potter’s (1997) validity research suggests that specificity of
the ASQ is high across questionnaire intervals.  Although advantages of utilizing the
ASQ include cost-effectiveness, parental involvement and flexibility in administration
procedures, it is not an appropriate instrument for use in a NICU follow-up program. It is
less than optimal for several reasons. Most importantly, the instrument begins screening
children at four months of age; a NICU Follow-Up clinic often sees children whose
developmental age, once an adjustment for prematurity has been made, is still less than
full term. For example, a six month old child born 28 weeks gestation (12 weeks
premature) has an adjusted age of three months old and consequently would not be able
to be appropriately screened until he or she was seven months of age.  Additionally, as
one of a NICU follow-up program’s functions is to provide hands-on fellowship training
for physicians, a neonatologist must monitor the children’s development; therefore a
questionnaire based screening instrument is not desirable.
Behavioral Assessment of Baby’s Emotional and Social Style (BABES).  The
BABES is a short checklist of social and emotional behaviors of children.  Designed for a
high-risk infant population, this instrument focuses on temperament, ability to self-
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soothe, and regulatory processes (Dobrez et al., 2001; Leonard, et al., 2001).  Examples
of items include transferring of blocks, looking for fallen items, types of vocalizations,
and pre-walking progression.  Neurological intactness in relation to active and passive
tone in the upper and lower extremities and quality of movement is also examined.  The
BABES has been validated on high-risk infant populations as wall as in normal test
construction.  Concurrent validity has been conducted with two other instruments
utilizing a population of infants born at term and preterm, and at high risk for
developmental delay (Macias, Saylor, Greer, Charles, Bell, & Katikaneni, 1998).
The BABES is not the most optimal screening instrument for use in a NICU
follow-up clinic as this measure focuses more on identifying social and emotional
problems rather than determining whether there is a need for in-depth developmental
assessment.
Child Development Inventories (CDI).   Formerly the Minnesota Development
Inventories (MDI), the CDI was designed to provide “systematic ways of obtaining in-
depth developmental information from parents” (Ireton, 1992, p. 1).  The author of the
CDI suggests that this measure enables parents to become collaborators rather than
passive observers in the assessment process. (Ireton, 1992).  The CDI utilizes three
separate instruments with 60 yes/no descriptions (Glascoe, 2002).  This parent
questionnaire assesses the eight developmental domains of social, self-help, gross motor,
fine motor, expressive language, language comprehension, letters and numbers.  It
addition, a General Developmental Scale is included.  The CDI is designed to
developmentally screen children between the ages of 15 months and 6 years. Similar to
other screening tools, the age range of children served in a NICU follow-up program
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extends below the CDI’s scope.  An additional concern with this instrument is that
various researchers (Diog et al., 1999; Shoemaker, 1993) demonstrate a large discrepancy
of levels of sensitivity among various studies.
Additional Instruments.   In addition to the parent report screening tools described
in detail, others exist but were excluded from use without an in-depth exploration because
they failed to meet the criteria of use in one NICU follow-up program. The Healthy Steps
“Quick Check Sheets” and the Parents’ Evaluation of Developmental Status (PEDS) are
two such instruments.  The Healthy Steps “Quick Check Sheets” provides professionals
with an overview of what to discuss at visits, a checklist of developmental areas to
observe, a checklist of parent-child interactions to observe, and questions to help parents
discuss parenting concerns (Dobrez et al., 2001). This instrument provides professionals
with a tool to aid in identification of potential concern but does not provide ample
information to be utilized as a NICU follow-up program’s screening measure.  The PEDS
is standardized to elicit parent concerns related to their child’s development.  This
screening instrument is appropriate for children from birth through the age of eight.  Ten
questions are used to elicit information and include one on cognition and eight related to
the developmental domains of expressive language and articulation, receptive language,
fine motor, gross motor, behavior, social self-help, and school skills.  Again, the brevity
of this tool deemed it inappropriate for use in a NICU follow-up program.
Direct Administration
Some screening instruments are directly administered by professionals or by
trained paraprofessionals.  Examples of direct administration include observation of a
child attempting a given task, direct elicitation from specific directions, and manipulation
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of the child's environment.   These instruments do not necessitate nor encourage parental
involvement in the screening process.  Examples of instruments utilizing direct
administration only include the Early Intervention Developmental Profile (EIDP), the
Brigance Screens, and the Diagnostic Inventory for Screening Children (DISC).
Early Intervention Developmental Profile (EIDP).  Considered a screening tool
by some (Ikle et al., 1995), the EIDP is a tool used to examine child development,
focusing on children ages birth through 36 months. Designed to bridge the gap between
assessment and program implementation, the EIDP is not a predictor of a child’s future
capabilities; rather it is an aid in predicting what type of skills a child is expected to
develop next (Rogers et al., 1981).  Six scales include information on perception/fine
motor, cognition, language, social-emotional, self-care, and gross motor development. In
addition to the lack of opportunity for parent reporting of a child’s abilities, this
instrument is not recommended for use with infants born prematurely because it does not
assess children born at less than 40 weeks gestation.
Brigance Screens.  Developed in the early 1980’s, the Brigance Inventory of
Early Childhood Development is an instrument which assess the six developmental areas
of fine motor, receptive language, expressive language, gross motor, self-help, and social
emotional skill (Glascoe, 2002) of children ages 21 through 36 months.  More recently a
new tool, the Brigance Infant and Toddler Screen (BITS), has been developed and
extends chronologically downwards to screen children from birth through two years.
There are two versions of the BITS, direct elicitation/observation and parent-
interview/self-report. Quicker than instruments such as the Denver II, the BITS can be
administered in 10 to 15 minutes. The Brigance screening instruments were not
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considered for use in a NICU follow-up program as a combination of the two Brigance
screening instruments would be required to meet the assessment needs of the clinic, does
not assess children whose chronological age is less than full term, and, similar to the
ASQ, omits examination of the cognitive domain.
Diagnostic Inventory for Screening Children (DISC).  Developed in Canada in the
late 1970’s, the DISC examines developmental status of children from the ages of birth
through five years.  This instrument examines eight areas including fine motor, receptive
language, expressive language, gross motor, auditory attention and memory, visual
attention and memory, self-help and social development.  Although this instrument is
referred to as a screening measure, Schwarting (1998) suggests that it is better described
as a useful instrument when administered between a general screen and full
developmental evaluation.  Several researchers agree that the materials used are not
appropriate, such as the use of buttons and items with small detachable pieces.
Furthermore, the test kit does not provide all items, such as a mirror, utensils and food,
and stairs (Schwarting, 1998; Watson & Henington, 1998).
Despite Schwarting’s (1998) reporting adequate content and face validity, other
reviewers of the DISC (Watson & Henington, 1998) cite various technical problems.  The
small standardization sample used a Canadian population (French, English, other) and,
therefore, is not reflective of an American population. More of a concern is the omission
of children with disabilities within this sample, of special importance as the DISC was
designed to identify such children.  Finally, there is no data regarding concurrent, or
predictive validity (Watson & Henington, 1998).
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Combination of Direct Administration and Parent Report
In 1975 P. L. 94-142 of the Individuals with Disabilities Education Act (IDEA)
included the provision that parents be part of the process for evaluating their child and
that parents have the authority to challenge the accuracy of the evaluation, program, or
placement of their child (Turnbull, Turnbull, & Wheat, 1982).  Recent recommendations
for best practice in early intervention views families as equal members who should join
together with staff and take part in the early intervention system, including all aspects of
their child’s care and at all levels of decision making (Mahoney et al., 1999).  The
screening process is a vital component of early intervention in which parents must be
viewed as members participating in the team rather than as clients of the professionals.
Screening instruments that combine direct administration and parent report enable parents
to be participants of this process.  A combination of professional observation and parental
input provides the most accurate picture of a child’s development.  Screening measures
which combine direct administration and parent report include the Battelle
Developmental Inventory Screening Test (Battelle), Bayley Infant Neurodevelopmental
Screen (BINS), and the Denver Developmental Screen-II.
Battelle Developmental Inventory Screening Test (Battelle). Developed in 1984,
the Battelle was designed to screen children, ages birth through eight years in the
domains of cognition, receptive language, expressive language, gross motor, fine motor,
psychosocial, and adaptive development (Ikle & Wittmer, 1995).  This screening
instrument is designed to be administered by professionals or trained paraprofessionals
and takes 10 to 20 minutes to complete.   According to Ikle and Wittmer (1995) the
validity of the Battelle is reported as high when compared with other instruments
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including the Vineland and BSID-II. Glascoe and others (1992) have also determined the
use of the Battelle to be well supported through validity studies. Ikle & Wittmer (1995),
however, express concerns related to the specificity of this screening instrument as there
is evidence of over-referral when compared to the Denver-II.
Although the Battelle included a diagnostic evaluation, it is not recommended for
children ages six months or younger, and therefore would not be a tool appropriate for
use with a NICU follow-up program’s population (Ikle & Wittmer, 1995).   Furthermore,
according to Ikle and Wittmer (1995) this screening test provides few items at each age
level (the total number of items is 85) when compared to other measures.
Bayley Infant Neurodevelopmental Screen (BINS). The BINS is a screening
instrument developed from items within the BSID-II.  An administrator directly elicits 11
to 13 items per three to six month age range within approximately a ten-minute time
frame. Assessing the development of children from the ages of three months through 24
months, each age range examines the child’s neurological processes, neurodevelopmental
skills and developmental accomplishments (Dobrez et al., 2001; Krug, 1998). Leonard
and others (2001) examined the appropriateness of the BINS as a screening technique for
children born prematurely at a low birth weight. The researchers suggest that the BINS is
a satisfactory screener for infants born prematurely and at low birth weight when used in
conjunction with known biologic and social risk factors (Leonard et al., 2001).
Other researchers found the BINS to demonstrate low sensitivity but high
specificity when predicting BSID-II results (Hess, Papas, & Black, 2004).  Their sample
included low income African American infants who were classified as high risk and were
administered the BINS at 6 and16 months and the BSID-II at 24 months.  Hess and her
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colleagues (2004) suggest that the BINS is an appropriate measure of developmental risk
for children who are at biological risk (e.g., premature infants) because it may capture
skill that continue to be problematic over time.  They argue that the BINS is not,
however, an ideal measure to predict development of infants who are environmentally at
risk with no biological risk factors because infants who are in high risk environments
have heightened risk for developmental delays after infancy (Hess et al., 2004).
The BINS strengths are related to a good normative sample, good organization of
the areas assessed and the scoring procedures (Benish, 1998; Krug, 1998). It is
recommended that administrators possess a graduate level knowledge of infant
development and handling. This high level of knowledge needed may result in limited
use of the BINS in educational and non-clinical settings (Benish, 1998).  Krug (1998)
further cautions that despite the BINS’ strength of identifying low- to moderate-risk
children who are developing appropriately, there is risk that the instrument also may
incorrectly categorize children as high to moderate-risk infants.  These false positive
identifications may lead children to be subjected to lengthy, unnecessary testing. The
main justification, however, for not using the BINS with a NICU follow-up program
population, however, is that this measure does not assess the development of children less
than three months of age.
The Denver II Developmental Screening Test (Denver II).  The Denver II is the
most widely used screening throughout the world (Dobrez et al., 2001). This screening
instrument is administered to children between birth and six years of age in order to
determine performance on age-appropriate tasks (Frankenburg et al., 1992).  Similar to
the MDS, the 125 item Denver II is not an IQ test; it is not a definitive predictor of future
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adaptive or intellectual ability, nor is it designed to generate diagnostic labels
(Frankenburg et al., 1992).  Areas of developmental function assessed include person-
social, fine motor-adaptive, language, and gross motor skills.
Standardization of the Denver II was conducted in 1988 by 17 screeners, trained
to a high inter-rater reliability, who administered each item between 440 and 1,309 times.
The sample population was a heterogeneous group of children from Colorado.  The
variables of sex, maternal education, ethnicity, and place of residence were analyzed to
examine differences in age at which children passed an item.  The standardization of the
Denver II was the only method of determining validity used; justified by the test’s
authors‘ suggestion that the test could not be correlated with other tests because all tests
are constructed slightly differently (Frankenburg et al., 1992).  Glascoe, Byrne, Ashford,
Johnson, Chang, and Strickland (1992), however, argue the following:
Validation in comparison to widely accepted diagnostic tests is essential since
this is the only method for determining how well each item performs in relation to
diagnostic measures or other performance criteria (e.g., school success) and
whether items actually measure meaningful aspects of child development (p.
1224).
The sensitivity and specificity of the Denver II is questioned by several
researchers (Committee on Children with Disabilities, 2001; Glascoe, 2002; Glascoe et
al., 1992). Despite the revisions that occurred to the original Denver Developmental
Screening Test, the Denver II manual omitted information regarding the measure’s
validity.  Researchers (Glascoe et al., 1992) argue that this omission is of concern
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because there is little proof that the revision is a viable improvement from the original
version of the test.
Glascoe (2002) reports that the Denver II’s levels of both sensitivity and
specificity are 44% dependent on how an administrator addresses questionable test
scores.  In an early study, researchers examined the validity of the Denver-II through
comparison with the BSID-II, Kaufman Assessment Battery for Children, Stanford-Binet,
4th ed., and the Vineland Adaptive Behavior Scale (Glascoe et al., 1992).  Similar to
Glascoe’s (2002) report of low level of specificity, the results of this study found a level
of 43%.  The level of sensitivity, however, was at a more acceptable level of 83%.
The low rates of specificity and the greatly varying rates of sensitivity provide
NICU follow-up programs evidence that the Denver II may not be the most optimal
instrument to screen children born prematurely.  Although the Denver II is a widely
utilized screening instrument, it does not offer items within each of the six developmental
domains; the domains such as fine motor and adaptive are not assessed separately.
Additionally, the administration of this instrument is lengthy and time consuming.
The most significant reason, however, that the Denver II is not appropriate with a
NICU follow up Program population is that it lacks items within the first six months that
assess children whose age at the time of the screening is still less than full term,
particularly less than 28 weeks gestation. According to one prominent neonatologist, L.
Blackmon (personal communication, January 26, 2003), there is a significant delay
before Denver II items are manifest and the time range in which they appear is broad.
The Denver II fails to use items that are appropriate for this age group’s developmental
status as well as for the quality of motor function, not merely the presence or absence of
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landmarks.  For example, within the gross motor domain, a one-month child will be
screened to determine if there are equal movements and if he can lift his head; no
information is obtained regarding the quality of these movements.
Bayley Scales of Infant Development, Second Edition (BSID-II)
Many studies have investigated the concurrent validity between instruments, such
as the CAT/CLAMS, the Battelle, and the CDI, with the BSID-II (Kube, Wilson,
Peterson, & Palmer, 2000; Provost, Crowe, & McClain, 2000; Wachtel, Shapiro, Palmer,
Allen, & Capute, 1994). Revised from the original Bayley Scales in 1993, the BSID-II is
considered as a widely accepted standard of infant development (Rossman, Hyman,
Rorabaugh, Berlin, Allen & Modlin, 1994) and was used as the benchmark to measure
concurrent validity in the current investigation. It is an in-depth evaluation that assesses
the development of children from birth through 42 months of age by the administration of
three subscales.  The Mental Scale (MDI) examines memory, problem solving,
conceptualization, language, and social skills.  Fine and gross motor are assessed with the
Motor Scale (PDI) and the Behavior Rating Scale examines arousal/attention,
orientation/engagement, emotional regulation, and quality of movement.  As the MDS
does not examine behavioral state, the BSID-II’s Behavioral Rating Scale will not be
considered within the context of the present study.
Standardization of the BSID-II is based on a heterogeneous sample of 1,700
children, including 50 girls and 50 boys in each age group (Salvia & Ysseldyke, 1999, p.
619-621). The BSID-II classifies the developmental status of children as accelerated
performance, within normal limits, mildly delayed, or significantly delayed.  The
classification status of a child is dependent on how much the MDI or PDI score (derived
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from raw scores) deviates from the norm; one standard deviation (15 points) below the
norm indicates a mild delay and two standard deviations below the norm indicates a
significant delay.  In addition to MDI and PDI scores, developmental ages can be derived
from raw scores (Bayley, 1993).  The developmental age is frequently used to determine
whether the percentage of delay is great enough to qualify a child for early intervention
services.  Although classification status is the recommended method for the BSID-II to
identify children with developmental delays (Bayley, 1993), developmental ages are
often the criterion set forth by states (e.g., Maryland) for acquisition of early intervention
services (Shackelford, 2004).  Similar to other concurrent validation studies (Palisano,
1986; Provost et al., 2000) the developmental age equivalent was used as the criterion
measure for this study.
Screening measures that have been examined concurrently with the BSID-II have
been previously discussed.  These instruments include the CDI (Diog et al., 1999), the
Battelle (Ikle & Wittmer, 1995), the BINS Benish, 1998; Krug, 1998), and the Denver II
(Glascoe et al., 1992).   The Clinical Adaptive Test/Clinical Linguist and Auditory
Milestone Scale (CAT/CLAMS) and Peabody Developmental Motor Scales (PDMS) are
among the assessment instruments concurrently compared to the BSID-II. The
CAT/CLAMS examines language, problem-solving abilities, and visual-motor skills for
children ages birth to 36 months of age.  Researchers (Kube et al., 2000) report a strong
concurrent validity between the CAT/CLAMS and the BSID-II (r = 0.89, p < .0001).  The
results of Provost and colleges’ (2000) concurrent validity investigation of the BSID-II
Motor Scale and the PDMS with a sample of two-year-old children suggest that there is a
very good to high correlation with age equivalent scores of the PDMS Fine Motor Scale
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(r = .87) and with the PDMS Gross Motor Scale (r = .87).  Further investigation of the
correlation of these standard scores, however, demonstrated a poor to unacceptable
correlation with both the PDMS’ Fine Motor Scale (r = .64) and Gross Motor Scale (r =
.49) (Provost et al., 2000).
Similarly to Provost and others (2000), Palisano (1986) examined the concurrent
validity of the BSID-II’s Motor Scale and the PDMS. Healthy infants born at full-term (n
= 23) and prematurely (n =21) were assessed with both tests at 12, 15, and 18 months of
age.  Results of this investigation suggest a good to high correlation on age equivalent
gross motor scores (r = .78 to r = .96) but yielded an unacceptable correlation with fine
motor scores (r = .20 to r = .57).  Palisano (1986) additionally found that with full-term
infants the mean BSID-II quotients were significantly higher than the Peabody gross
motor quotients.  The findings of these studies suggest that although the BSID-II is the
current benchmark for examining the concurrent validity of early childhood
developmental assessment, one should be cognizant of the BSID-II’s limitations and
proceed with caution (Provost et al., 2000).  Overall, however, the BSID-II provides a
strong standard of assessment of infants and young children and comparison with this
instrument will yield important information about tools, such as the MDS, which need to
undergo thorough validation procedures.
Bayley’s manual (1993) includes an examination of the BSID-II use with a
population of infants born prematurely.  The sample (N = 57) population’s MDI score
was approximately 4/5 of a standard deviation below  (M = 88.6) the normative sample
and the PDI score was 1 standard deviation below (M = 83.5) the normative sample.
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These results suggest that despite a correction for prematurity, children born at less than
36 weeks gestation are more likely to perform below their same age peers.
Need for New Screening Measure
As illustrated in Table 3, not one of the twelve instruments discussed completely
satisfied seven of the eight screening needs of children who are premature.  The criterion
of validity is not included in this table as all instruments included in the review had some
validity measures.  Meeting the following screening criteria is important to ensure that
children in this population requiring further, in-depth assessment are identified as early as
possible: (a) screens at least six developmental domains, (b) uses minimal materials, (c)
easy and speedy administration, (d) tests infants whose adjusted age at time of screening
is less than full term (40 weeks gestation), (e) provides hands-on assessment, (f) includes
parent report, and (g) includes a professional evaluation of the quality of the child’s
performance.
While screening instruments including the ASQ, BABES, CDI, Healthy Steps and
PEDS use minimal materials, are easy and speedy to administer, and provide opportunity
for parent input, none provide hands-on assessment nor is it possible to assess children
whose age at time of testing is considered to be less than full term.  Of this group of
instruments, only the CDI screen provides information on at least six developmental
domains.  These domains, however, include letter and number skills; not often applicable
for screening very young children.  The EIDP, Brigance Screen, BITS, and DISC screen
at least six domains and are again easy and speedy to administer but do not consider
parent report in determining results. Both the Brigance Screens and the DISC utilize more
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than minimal materials and all three of these instruments again are unable to assess
children less than full term.
Although the BINS combines parent report and direct administration, as it is
adapted from the BSID-II, it uses more materials and is not as easy to administer as other
instruments.  Of the other instruments which combine direct administration and parent
report, including the Battelle, Denver II comes the closest to effectively meeting the
screening criteria.  As with all other instruments, the Battelle and Denver II do not have
the ability to assess children who are less than full term.  Furthermore, as discussed, it is
suggested that the Battelle does not provide enough items at each age interval (Ikle &
Wittmer, 1995), and the Denver II’s specificity and sensitivity has been challenged by
many researchers (Committee on Children with Disabilities, 2001; Glascoe, 2002;
Glascoe et al., 1992).  Finally, none of these instruments included a professional
evaluation of the quality of a child’s performance.
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Table 3
Criteria for Screening Infants Born Prematurely
Tool Screens
at least
six*
domains
Uses
minimal
materials
Easy and
speedy to
administer
Tests
Adjusted
Age
 < term
Hands-on Parent
Input
Eval.
Of
quality
Parent Report
ASQ X X X
BABES X X X
CDI X X X X
Healthy
Steps
X X X
PEDS X X X
Direct Administration
BITS X X X
Brigance X X X
DISC X X
EIPD X X X X
Direct Administration & Parent Report
Battelle X X X X X
BINS X X X
Denver II X X X
MDS X X X X X X X
* Developmental domains: cognitive, fine motor, gross motor, language, social-
emotional, adaptive
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The Maryland Developmental Screen (MDS)
In response to the need for a screening instrument that meets the criteria described
(see Figure 1) the MDS was created by Brenda Hussey-Gardner (2003) at the University
of Maryland Medical System (UMMS). The instrument that the UMMS NICU Follow-
Up Clinic used prior to the MDS’ conception was the Maryland Premature Development
Inventory (MPDI).  Developed in 1987 by Renee Wachtel, the MPDI examined the
developmental domains of gross motor, fine motor/adaptive, language/auditory, and
visual/problems solving. The MPDI was designed to examine children whose age at the
time of administration was considered to be less than full term.  With this measure, it was
possible to screen a child whose post conceptual age (PCA) was 36 – 40 weeks gestation,
through the age of 36 months. The clinical observation and/or parent report of
chronologically age appropriate items was recorded to determine a developmental
quotient.
Several factors led the UMMS NICU Follow-Up Clinic to discontinue use of this
instrument. Professionals who used this assessment strongly believed that it did not
adequately meet the screening needs of a NICU follow-up program’s population
(personal communication with B. Hussey-Gardner, April 28, 2005). Items used to
determine skills were provided monthly for the first year; after one year of age, items
were administered every two months, and after two years of age items were only
provided at six-month intervals.  There was concern that this widening gap in test items
delayed some children from being identified as requiring further in-depth assessment.  In
addition, the MPDI did not screen the six developmental domains separately. Finally, the
MPDI was not subjected to rigorous validity procedures.  Consequently, this screening
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instrument was no longer used at this clinic and the new MDS replaced the instrument’s
function.
The purpose of the MDS is to “identify infants and toddlers whose developmental
progression may be delayed and would benefit from more in-depth evaluation” (Hussey-
Gardner, 2003).   As with other screening instruments the MDS does not replace formal
evaluation/assessment procedures nor is it intended to elicit diagnosis.  Unique to this
new measure, it is designed to be used to screen the development of children 30-32 weeks
gestation through 39 months of age. The domains screened with the MDS include
cognitive, social-emotional, adaptive, gross motor, speech and language, and fine motor
development.
Similar to the BSID-II, the MDS may be characterized as “theoretically eclectic”
(Bayley, 1993, p. 2).  The 181 test items were compiled from screening instruments,
assessments, curriculums, and a broad cross-section of infant and child research.  As with
the BSID-II, this approach has yielded a representation of diverse viewpoints with no
particular theory driving the content. Through a validation process in which professionals
reviewed domains for which they had expertise, MDS test items were placed at the
correct age and that the items represented key milestones for that age.  Nine professionals
have reviewed test items within their developmental expertise.  Professionals who
reviewed the MDS included a developmental pediatrician, neonatologist, physical
therapist, occupational therapist, speech and language therapist, psychologist, and special
educator.  Each individual examined the domain in which they were most knowledgeable
and provided a critique on the appropriateness of selected assessment items.  The
professionals verified that each item was placed at the correct age and that the items were
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representative of key milestones.  Modifications of the MDS were made based on the
reviewers recommendations until consensus was achieved (Hussey-Gardner, 2003). After
one year of piloting, additional changes were made to the MDS.  For example, the six
month cognitive skill of ‘lifts cup by handle” was omitted because most children were
observed to reach around the handle to grasp the cup.  Many parents suggested that
sippee cups do not have handles and therefore the children were not aware of their
function.
The MDS is scored by recording whether each item is observed as pass by the
examiner (O), reported as a pass by the parent (R), or neither observed nor reported as a
pass (N).  Unique to this measure, the quality of every item is additionally evaluated by
the professional and recorded as either a typical (T) or atypical (A) performance.  Based
on the O, R, and N scores in each age range, a child is considered to pass the screen, be
suspect, or fail that particular age range.  A child passes the screen if all items are scored
either O or R.  A child is considered suspect if one item is scored N but all other items are
scored O or R.  A child fails the screen if a N is scored in the current and preceding age
range in one or more domains.  The examiner also indicates whether the quality of the
child’s performance is typical and also notes whether the parent feels that the child
performed as they expected. If a parent reports that the child did better than expected a
‘+’ is noted next to the “N”; a ‘—‘ indicates that the child’s performance was not as
optimal as expected. An example is provided in Figure 2.
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Figure 2.
Example of MDS Items 
Cognitive Language Social-Emotional Adaptive
Gross
Motor
Fine
Motor Results
Tracks
ring 30o
O
R
A
N
Throaty
noises
O
R
A
N
Quiets to
voice/face
O
R
A
N
Can
maintain
alertness
1 hour
O
R
A
N
Head up
in prone
O
R
A
N
Hands
fisted
O
R
A
N
P S F
T A
Y  N
Key:   O = Observed, R = Reported, A = Atypical quality, N = Neither observed nor
reported.  P = Pass: Child receives O or R for all items in age, re-screen at next visit, S =
Suspect: Child receives N in one or more domains but receives O or R for all items in that
domain at preceding age range, re-screen at next visit, if two consecutive suspects refer to
developmental team, F = Fail: Child receives N in current & preceding age range in one
or more domains, refer to developmental team.  T = Typical quality of performance & no
A’s marked in row, A = Atypical quality of performance with at least one item marked A
in row, refer as needed.  Y = Yes child’s performance was as parent expected, N = No
child’s performance was not as parent expected (+ indicates better than expected, -
indicates not as good as expected)
In the setting in which it is currently used, the NICU Follow-Up clinic, the
professionals (e.g., neonatologists) who administer the MDS have training and
qualifications which should enable them to demonstrate reliability in identification of
atypical development.  In another setting, the reliability of the identification of an
atypical quality may be problematic because the administrators may not have the
expertise to identify potential problems.  Clinical judgement will not be sufficient in other
environments and therefore the MDS manual is currently under revision so that quality of
performance on test items will be clearly defined.
As the survival rate for infants born prematurely increases, researchers suggest
that risk for these children developing disabilities increases as well (Berger, Holt-Turner,
Cuppoli, Mass, & Hagerman, 1998; Linden et al., 2000; Resnick, Eyler, Nelson, Itzman
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& Bucciarelli, 1997).  Therefore it is important to frequently screen and assess this
population’s developmental status.  Few studies, however, were found that examined any
screening instrument’s validity when used with a population of children born
prematurely. In addition to identifying children in need of early intervention as early as
possible, accurate developmental screening reminds professionals to observe and record
clinical observations and assists in appropriately allocating health care services
(Committee on Children with Disabilities, 2000; Glascoe et al., 1992; McLean et al.,
1996; Sonnader, 2000).
The administration of a developmental screening test to infants and toddlers born
prematurely occurs through parent report, direct report, and a combination of parent
report and direct administration.  Twelve screening instruments were reviewed to
determine which, if any, were appropriate to measure the developmental status of infants
born prematurely.  This review yielded no validated developmental screening instruments
which met the criteria of (a) six developmental domains, (b) use of minimal materials, (c)
ease and speed in administration, (d) ability to test young infants with adjusted age of less
than term, (e) hands-on assessment, (f) parent involvement in the screening process, (g)
professional evaluation of the quality of the child’s performance and (h) valid screening
measure of developmental status.
In response to the need for a new screening instrument, the MDS was created.  As
with other screening instruments, the MDS is neither intended to replace formal
assessment procedures nor to elicit diagnosis.  Rather, the purpose of this instrument is to
identify children whose development may be delayed and who would benefit from more
in-depth developmental evaluation.  The MDS screens children, whose ages range from
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30-32 weeks PCA through 39 months, for potential delays in cognitive, language,
adaptive, social-emotional, gross motor, and fine motor development.  Although the
MDS appeared to meet an unmet need for accurately screening infants and toddlers born
prematurely, it had not yet to be subjected to rigorous validation procedures.  To respond
to this need this study was conducted to determine the concurrent validity of the MDS
when compared to the “gold standard” (Sattler, 1992, p. 321) of developmental
assessments, the Bayley Scales of Infant Development, Second Edition (BSID-II), with
infants and toddlers who were born prematurely.  To address this issue the following
three research questions were asked:
1. What is the sensitivity of the MDS when concurrently administered with
the BSID-II?
2. What is the specificity of the MDS when concurrently administered with
the BSID-II?
3. What is the overall hit rate and chance hit rate of the MDS when compared
to the BSID-II?
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CHAPTER III
Research Methodology
The purpose of this study was to investigate the concurrent validity of the
Maryland Developmental Screen (MDS) when compared to the Bailey Scales of Infant
Development, Second Edition (BSID-II) in a population of infants and toddlers born
prematurely. To address this issue the following three research questions were asked:
1. What is the sensitivity of the MDS when concurrently administered with the
BSID-II?
2. What is the specificity of the MDS when concurrently administered with the
BSID-II?
3. What is the overall hit rate and chance hit rate of the MDS when compared to the
BSID-II?
  A description of the site, participants, research methodology, instrumentation, field
procedures, data collection and recording, data processing and analysis, and
methodological assumptions is provided.
Site
This study was conducted at the University of Maryland Medical Systems
(UMMS) NICU Follow-Up Clinic. The purpose of the clinic is to: (a) coordinate
neurodevelopmental screening from birth to age three, (b) provide multidisciplinary
support, including speech and language therapy, social work, physical therapy,
occupational therapy, psychology, and early intervention service coordination for
children who have been discharged from the NICU, and (c) provide consultation on
unresolved medical problems following NICU discharge.   The clinic’s two components,
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screening and assessment, coordinate with primary care to provide optimal
developmental and medical monitoring.  Children who are born at 36 weeks gestation or
less receive an age adjustment for their level of prematurity until their adjusted age is 12
months.  At either their chronological age or adjusted age, the MDS and the medically
based neurodevelopmental examinations are administered.  The MDS screens the
domains of cognition, fine motor, gross motor, adaptive, social-emotional, and language
development. The neurodevelopmental examination assesses a child’s “neuromuscular
status (e.g., tone), primitive reflexes (e.g., moro), developmental reflexes (e.g., grasp),
protective reactions (e.g., downward parachute), involuntary movement (e.g., tongue
thrust), deep tendon reflexes (e.g., ankle), mobility (e.g., sit to crawl), fine motor (e.g.,
transfer), and oral reflexes” (Hussey-Gardner, 1995, p. 56). Although the medical
neurodevelopmental exam is a component of each clinic visit, the results were not
collected, nor part of this study’s analysis.  The purpose of this study was to investigate
the validity of the MDS with infants and toddlers born prematurely.  It was determined
that by including this information, the likelihood of generalizability, thus validity, of this
study would decrease because in different settings (e.g., early childhood centers)
neonatologists are often not present to collect medical information.
A child who passes both the MDS and neurodevelopmental screens attends
routine appointments at the NICU Follow Up Clinic at 3, 6, 9, 12, 18, 24, 30, and 36
months of age and is screened with both exams at each appointment.  Although not
considered a routine appointment, a child may also been seen at 39 months of age if they
have missed their 36 month appointment or if the clinic staff make new service
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recommendations or provide a new diagnosis at 36 months of age.  Children who are 24
months of age also receive the BSID-II as part of routine care.
If a child’s development is suspect or delayed, screening or evaluation may occur
at more frequent intervals. In addition, if the results of the MDS indicate that a child’s
development is suspect or delayed, one or more developmental staff member(s), whose
expertise matches the child’s needs, will conduct a more in-depth assessment. Based on a
child’s individual needs, the developmental team staff members who may conduct
assessments include an occupational therapist, physical therapist, speech and language
therapist, psychologist, and special educator.  If the child fails the MDS or is suspect on
two consecutive administrations, the child is referred to be seen by the developmental
pediatrician and one or more members of the developmental team.  Once the
developmental pediatrician evaluates a child, he or she is no longer screened through the
MDS, unless all developmental concerns are resolved.  For the purpose of this
investigation, however, all children whose families agree to participate, regardless of
whether they routinely received the MDS or were followed by the developmental
pediatrician, received both the MDS and BSID-II.
Participants
The participants in this study were infants and young children who were followed
by the UMMS NICU Follow-Up Clinic.  A list of factors that serve as eligibility criteria
for attending the NICU Follow-Up Clinic and that place children at-risk for
developmental delay is provided in Table 4.  All infants who attend the NICU Follow-Up
Clinic were inpatients in the UMMS NICU or one of six other Maryland NICUs (Hussey-
Gardner et al., 2002) at birth and had been discharged based on their medical stability.
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The children who attend the UMMS NICU Follow-Up Clinic are representative of the
total population of premature infants born in Maryland, in terms of SES, race/ethnicity,
and diagnoses.  There are approximately 650 infants who are admitted to UMMS NICU
per year.  These infants represent families from all jurisdictions in Maryland, as well as
from surrounding states.
Table 4.
UMMS NICU Follow-Up Clinic Criteria Conditions
 Birth weight < 1,500 grams
 Gestational age <32 weeks
 Apgars < 5 at 5 minutes
 Intrauterine growth retardation
 Intraventricular hemorrhage >Grade II
 Congenital infection
 Congenital anomalies
 Ventriculomegaly
 Porencephaly
 Hydrocephalus
 Microcephaly
 Hypoxi-ischemic encephalopathy
 Periventricular leukomalacia
 Seizures
 Meningitis
 Broncopulmonary dysplasia
 Hearing impairment
 Vision impairment
 Abnormal neurolgic exam at discharge
 
 Once discharged from the UMMS NICU, most children attend the UMMS NICU
Follow-Up Clinic.  Additionally, the clinic receives referrals from six other NICUs
located in Maryland.  In 2004, 648 children attended the UMMS NICU Follow-Up Clinic
for one or more visits.  The ethnicity of these children was as follows: 361 (55.7%)
African American, 221 (34.1%) Caucasian, 13 (2%) Hispanic, 7 (1%) Asian, 3 (.5%)
Native American, and 43 (7%) Other/Unknown. Although the majority of families who
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attend the NICU Follow-Up Clinic reside in Baltimore City, families travel to the clinic
from all jurisdictions in Maryland. The geographic representation of the clinic population
in 2004 was as follows: 517 (78%) Greater Baltimore, 49 (8%) Capital Region, 13 (2%)
Eastern Shore, 31 (5%) Southern Maryland, and 19 (3%) Western Maryland.  The
families varied in respect to socio-economic status, ethnic group, and religion.  There is
also diversity in family structure, including two-parent and single-parent families,
grandparent caregivers, and foster/adoptive parents.
Approximately one-third (105) of all children who attend the clinic receive early
intervention services from one of Maryland’s 24 counties’ Infants and Toddlers
Programs.  In the state of Maryland, if a child demonstrates a developmental delay of
25% or more in one or more areas of development, is developing atypically, or has a
medical condition in which there is a high probability for developmental delay, early
intervention services are provided to the family at no cost (Maryland Infants and
Toddlers Program, 2000).  Services may include, but are not limited to, special
instruction, speech and language therapy, occupational therapy, physical therapy, and
early intervention service coordination.
 Caregivers were recruited for the study as they were waiting for their infants’
appointments in one of the NICU Follow-Up Clinic examination rooms.  A sample of 81
children who were born at less than or equal to 36 weeks gestation and whose
chronological ages ranged between 3 and 38 months were recruited for participation in
this study.  To have a sample representative of all age groups, the recruitment for the
sample was stratified to ensure that there were at least 10 children represented for each
visit level (i.e., 3, 6, 9, 12, 18, 24, 30, and 36 months of age).  Exclusion criteria for the
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proposed study included children whose caregivers did not speak English.   Any child
born at 37 weeks gestation or greater was also excluded, as these children were not
considered to be premature.  Those children whose adjusted age was less than or equal to
16 days old were additionally excluded because the BSID-II is not capable of assessing
children this young.  Finally, children who visited the clinic at 38 months of age or older
were excluded as these visits were not considered to be routine.
 Instrument Selection
 The present study examined the validity of the MDS by determining sensitivity
and specificity identification rates of children born prematurely who were and were not
developmentally delayed as measured by BSID-II assessments.   Although rarely stated
in academic literature, clinically, the BSID-II is considered to be a gold standard in early
childhood assessment.  Sattler (1992) describes this instrument as “by far the best
measure of infant development and provides valuable information about patterns of early
mental development” (p. 321).  The BSID-II is the most commonly used standard against
which most other screening instruments have been compared.   The BSID-II has been
used to examine the concurrent validity of the Harris Infant Neuromotor Test (Harris &
Daniels, 2001) and the Bayley Infant Neurodevelopmental Screener (Leonard et al.,
2001) with populations of infants born prematurely. Researchers have also used the
BSID-II to establish validity of screening instruments when used with infants born at full
term.  These instruments include the Denver II (Glascoe et al., 1992), the Child
Development Inventory (Diog et al., 1999; Shoemaker et al., 1993) and the Brigance
Screens (Glascoe, 2001).   Finally, the BSID-II has been used as the standard to which
other in-depth assessments including the Clinical Adaptive Test/Clinical Linguist and
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Auditory Milestone Scale (Kube et al., 2000; Watchel et al., 2000) and the Battelle (Ikle
& Wittmer, 1995) are compared. Unlike the MDS, the BSID-II does not specifically
address the six developmental domains; rather, the manual reports that domains are
assessed directly by various items in the Mental Developmental Index (MDI) and
Psychomotor Developmental Index (PDI).  This issue was explored through the analysis.
 Due to wide use of the Denver II, initial consideration was given to comparing the
MDS to the Denver II.  However, a decision was made to not additionally compare the
MDS to sensitivity and specificity rates of the Denver II. Researchers have found low
rates of both sensitivity (44% to 83%) and specificity (43% to 44 %) when relating the
Denver II to other assessments including the BSID-II (Glascoe, 2002; Glascoe et al.,
1992). As indicated earlier, a 70% sensitivity level and a 70-80% specificity level are
acceptable rates for developmental screening (Sonnader, 2000). Although the Denver-II’s
sensitivity level was 83% in one study (Glascoe, 1992), the range (44% to 83%) among
studies is too great.   The low sensitivity and specificity rates demonstrated, as well as the
inappropriateness of the Denver II’s test items for screening children less than six months
of age, resulted in the omission of the use of this screening tool in the present study.
Methods and Procedures
Prior to initiating data collection, Institutional Review Board (IRB) approval was
obtained from the University of Maryland Medical School (UMMS) and the University
of Maryland, College Park. The student researcher was trained to administer both the
MDS and the BSID-II. Reliability was established among administrators prior to
initiation of data collection.  Reliability of the MDS was established by comparing the
neonatologists’ and student researcher’s administration and scoring of 12 (15% of the
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sample) administrations with the clinic coordinator, who was responsible for training the
UMMS NICU Follow Up Clinic staff to use the MDS.  Reliability of BSID-II index
scores was established between the staff psychologist, who routinely administered the
BSID-II, and the student researcher by scoring 12 MDI (15% of the sample) and 12 PDI
assessments.
The protocol for establishing reliability on both the BSID-II and the MDS was the
same.  Children were sequentially selected at random so that there were four children
represented for each chronological age range of (1) 3 through 12 months, (2) 13 through
25 months, and (3) 26 through 37.5 months. The student researcher and psychologist
alternated administration and scoring of the BSID-II.  Neonatologists and the clinic
coordinator simultaneously scored the MDS while alternating administration of the
screen.  The correlation of the total score of each test administered resulted in a reliability
coefficient for the scorers obtained by the Cohen’s Kappa.  An interrater reliability
exceeding .80 for the MDS and .90 for the BSID-II respectively was desirable as
determined by the agreement between scores from tests administered by the examiners
prior to data collection.  Additional interrater reliability was re-established through
monthly periodic checks.
Upon agreement to participate, the families were asked to sign a consent form
(see Appendix B).  During clinic visits, a neonatologist administered the MDS to children
whose development is typical or suspect at 3, 6, 9, 12, 18, 24, 30, and 36 months of age.
If a child did not receive the MDS as part of routine care (i.e., received follow-up by the
developmental pediatrician) the student researcher administered the MDS.  Data was not
collected on children whose corrected age was less than 16 days old because the BSID-II
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did not have the ability the assess children this young.  All children who are 24 months of
age, as well as those whose cognitive development was found suspect or delayed by the
MDS, were routinely administered the BSID-II by the clinic’s psychologist.  When a
child was not scheduled to receive the BSID-II as part of routine care, the student
researcher administered the assessment.  To preserve the independence of two
administrators, no one individual administered both the MDS and BSID-II to any one
child.
A random table of numbers was to be used to determine whether the MDS or the
BSID-II was administered first. This, however, did not occur, and is an acknowledged
limitation of this study. The nature of the clinical environment, time constraints, or parent
preference made it difficult to control the order of assessments.  Instead, the order of the
testing was most often dictated by the neonatologists’ availability.  For example, if a
neonatologist was examining another NICU Follow-Up Clinic patient, then the BSID-II
would be administered first; if the neonatologist was ready to examine the child in the
study, the MDS would be administered first.  All testing procedures occurred in one of
the UMMS NICU Follow-Up Clinic’s available examination rooms.  Standardization of
the testing environment was accomplished by ensuring that each room included a child’s
table and chairs, and a floor mat.  The data collected was kept in a locked file box until
the appropriate sample population was gathered.  All analysis was completed through the
use of the Statistical Package for the Social Sciences.
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Administration of the MDS
The clinic coordinator established reliability with neonatologists prior to the
initiation of data collection. Reliability was established with 1.0 agreement obtained
using a Cohen’s Kappa calculation with 12 subjects whose data were not included in the
study’s sample. The majority of children were tested with the MDS by a neonatologist as
part of routine care.  Children who did not receive the MDS as part of routine care were
given the screen by the clinic coordinator.  These children included those who had
already been identified as developmentally delayed, and therefore were most often
examined by the developmental pediatrician and received a more in-depth assessment
such as the CAT/CLAMS or the BSID-II.
As there is dispute in the literature as to when age adjustment should be
discontinued, age correction followed the MDS manual’s protocol.  (Brenbaum &
Batshaw, 1997; Rickards, Kitchen, Doyle, & Kelly, 1989; Wilson & Michaeleen, 2004).
The administrator adjusted the child’s age in order to give the screen using the most
appropriate test items. The MDS was administered at the child’s adjusted age if the child
was born at or less than 35 weeks gestation and the age continued to be adjusted until the
child’s adjusted age was 12 months old.  The adjusted age was computed by subtracting
the number of weeks of prematurity from the child’s chronological age. Rationale for
adjusting a child’s age until the adjusted age of 12 months was provided in the MDS
manual (Hussey-Gardner, 2003):
(1) The earlier a child is born, the longer the child needs to ‘catch-up’, and (2)
adjustment beyond the age of 12 months may result in a child not being referred
for further evaluation and early intervention services at an early enough age (p. 2).
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Once an adjustment for prematurity was calculated, all items in an appropriate age
row were administered.  A score of  ‘O’ (observed), ‘R’ (parent report), or ‘N’ (not
observed or reported) was given for each item.  Additionally, each item was scored either
‘A’ (atypical) or ‘T’ (typical) to reflect the professional’s evaluation of the quality of the
child’s performance.  If an ‘N’ was scored within any domain, the examiner tested items
at an earlier age.  For example, if a child was screened at 21 months of age and neither
observed by the administrator nor reported by the parent as capable of the “unzips zipper”
skill, then the 18-month skill of “uses a spoon with little spilling” was also administered
(see Figure 3).  A child passed the screen if an ‘O’ or ‘R’ was scored for all items within
the appropriate age range.   A child who passed continued to be re-screened at the NICU
Follow Up Clinic’s routine scheduled appointments.
 A score of ‘N’ in one or more domains at the appropriate age range with an ‘O’
or ‘R’ for items in the preceding age range yielded a suspect result.  The child’s
development was considered to be questionable and anticipatory guidance was provided
to the parent.  The child was re-screened within three months and if she or he scored fail
or suspect on the consecutive screen, a referral for a developmental assessment was
made.  A child failed the MDS if he or she received an ‘N’ in the appropriate and
proceeding age range in one or more domains.  A failure on the MDS indicated that a
child may not be developing skills typical for children of the same age and further
assessment was necessary.
A more in-depth evaluation in the domain of concern, should be conducted as
soon as possible.  For example, if a child failed the language domain, a speech and
language pathologist should be a participant of the subsequent evaluation and based on
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assessment results, appropriate early intervention referrals should be completed.  The
MDS additionally consists of two qualitative components.  First, the professional
administrator indicated whether or not the child’s development presented with typical or
atypical quality.  An example is that a child is walking at an appropriate age but has an
atypical quality because he or she drags the left leg.  If any individual test item was
scored atypical, then the overall test was scored atypical.  Second, the parent had the
opportunity to report whether or not the child performed as expected.  If the child did
better than expected, anticipatory guidance and parent education was tailored to the
parent’s understanding of development. If the child did not perform as expected it may
have indicated that there may be a better time to evaluate the child (e.g., not during not
nap time); however, the screening results were still considered valid as parent report is
used to score the screen as well as professional observations.
Figure 3
Example of Scoring the MDS
Screen
Age
Adaptive O R A N Results
12 Takes off hat, shoes socks O R A N P S F – T A
Y N
15 Uses spoon with little
spilling
O R A N P S F – T A
Y N
18 Unzips zipper O R A N P S F – T A
Y N
21 Wipes nose if given a
tissue
O R A N P S F – T A
Y N
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Administration of the BSID-II
Prior to initiating this study, reliability on the BSID-II was established.  The
researcher and psychologist reached an agreement of 1.0 using Cohen’s Kappa with 12
subjects (15% of the sample). The agreement between evaluators was based upon
whether a subject’s developmental age was less than 25% delayed or 25% delayed or
greater.  Data obtained for these subjects were not included in the sample population.
Once reliability was established between administrators, each child whose family
was willing to participate in the study was administered the mental developmental index
(MDI) and the psychomotor developmental index (PDI) of the BSID-II by either the
psychologist or the student researcher.  Either the psychologist or the student researcher
administered the assessment in a patient examination room at the clinic.  The age range in
which the BSID-II was administered was determined by a calculation of the child’s age
with an adjustment for prematurity.  To administer the BSID-II the examiner
administered items that were scored as credit (C) or no credit (NC).  Scores of the MDI
and PDI are standardized so that there is a mean of 100 and a standard deviation of 15.
Raw scores were obtained by adding the number of items for which the child received
credit to all the items below the basal item.  Raw scores were determined based on the
standardization tables provided for each age in the test manual.   The raw scores were
then used to determine an age equivalent score to indicate whether the child was 25%
delayed.
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Demographic information
Demographic information was gathered regarding the child including date of
birth, gestational age, sex, race, birth weight, diagnosis (while in the NICU and current),
family member(s) present at the exam, and whether the child was involved in the early
intervention system (See Appendix C for the Demographic Questionnaire).  Family
information was also gathered, including Maryland county of residence as well as and the
parent’s age and marital, employment, and income status. The first nine questions on the
demographic form were obtained through a chart review and the following eight were
obtained through parent interview.  Descriptive statistical procedures conducted on the
demographic data included measures of central tendency (mean) and measures of
variance (range and standard deviation).  This information was used to analyze variables
that may have contributed to trends in the rate of referrals of children who reportedly
require more in-depth assessment.
Data Analysis
An investigation of the concurrent validity of the MDS was conducted by
analyzing the data to determine the instrument’s rates of sensitivity and specificity as
determined by the criterion, the BSID-II assessment.  This was accomplished by
examining the true positive, false positive, true negative, and false negative rates of MDS
scores as measured by BSID-II assessment results. Demographic data was also analyzed
to identify potential referral trends and to provide descriptive information regarding the
sample.
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The Hit Rate Model
The Hit Rate Model (Lichtenstein and Ireton, 1984), which is descriptive in
nature, was used to determine whether MDS scores concurrently predicted BSID-II
scores, thus identifying which children were in need of early intervention services.  The
hit-rate model “provides a methodological tool for determining the validity of a screening
process or for comparing one prospective screening process with another” (Lichtenstein
& Ireton, 1984, p. 230).  This model summarizes the relationship between the outcome of
a screening measure and the actual status of an individual in a given population
(Litchtenstein & Ireton, 1984).  In the case of this study, the outcome of the screening
measure was a child’s classification on the MDS and the actual status referred to the
classification outcome (i.e., pass or fail) on the criterion measure, which was the BSID-II.
Despite the fact that the BSID-II has two classification categories (< 25% delayed
or >25% delayed) and the MDS has three classification categories (pass, suspect, or fail)
the two instruments were compared. The three MDS categories of pass, suspect, and fail
were collapsed into binary categories for analysis.  Children who received a suspect
classification when screened with the MDS were grouped with children who passed the
screen.  Justification for grouping pass/suspect together was that children were not
expected to exhibit developmental delays if they receive a screening result of suspect.  In
a clinical setting, these children would be monitored more closely but not referred for
more in-depth evaluation.
Results of the BSID-II were collapsed into binary categories to indicate a
developmental delay versus a non-delay using a 25% delay criteria. The decision to group
children into the categories of 25% or greater delay and less than 25% delay was made
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because in the state of Maryland, children are eligible for early intervention services if
they demonstrate a delay of 25 % or greater.  Despite the considerable variability among
states in the quantitative description of developmental delay and the wide range of the
level of delay that is required by states for eligibility for early intervention services, a
25% delay is one of the most common quantitative criteria used (Shackelford, 2004).
This fact provided evidence that the results of this study would be applicable to many
states that follow the same eligibility guidelines as Maryland.  Age equivalents associated
with raw scores provided by the BSID-II manual were used to determine a 25% delay or
non-delay. For example, a 24-month-old child whose age equivalent was 17 months on
the mental or motor scale would be considered to be developmentally delayed on the
BSID-II.
Children who were screened by the MDS were categorized by two outcomes.
They were either categorized as screening positive, meaning that they were at a high risk
for developmental delay and needed to be referred for further assessment through the
BSID-II or as screening negative, therefore considered low risk and did not need to be
referred.  Following Lichtenstein and Ireton’s guidelines (1984), based on these two
screening outcomes there were four possible results for each child tested:
(1) True Positive: A child was referred by the screening procedure and failed the
BSID-II (the MDS was accurate).
(2) True Negative: A child was not referred by the screening procedure and did
fail the BSID-II (the MDS was accurate).
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(3) False Positive: A child was referred by the screening procedure but did not
fail the BSID-II (the screen yielded an over-referral).
(4) False Negative: A child was not referred by the screening procedure but
failed the BSID-II (the MDS inaccurately yielded an under-referral).
 When taking into account the four possible screening results, the indices of
sensitivity, specificity, overall hit rate, and chance hit rate were determined (Speece &
Cooper, 2004). Sensitivity, in terms of hit rate analysis, refers to the percentage of
subjects correctly detected at screening as having a developmental delay.  Specificity is
the percentage of subjects correctly passed by the screening due to the absence of a
developmental delay (Speece & Cooper, 2004).
 The rate of false positives was calculated to provide evidence of the level of
specificity of the MDS.  For example, a high rate of false positives would yield lower
specificity and lower overall hit rates.  The rate of false negatives was related to the
sensitivity of the MDS.  A high rate of false negatives would yield lower sensitivity and
lower overall hit rates (Speece & Cooper, 2004). The overall hit rate, defined as the
“proportion of accurate screening decisions out of the total number of screening
decisions” (Lichtenstien and Ireton, 1984) was calculated. The chance hit rate was
additionally calculated to address the potential for a deceptively high overall hit rate.
(Speece & Cooper, 2004). The chance hit rate indicates how many subjects would, by
chance alone, obtain the same screening outcome. Chance hit rates were considered when
analyzing this data because although the majority of children (67%) will develop age
appropriately, 33% children born at VLBW are at an increased risk for neurological
problems (Nadeau et al., 2001).  Rates of developmental problems with preschoolers fall
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in the range of 5-10% of the population and the rate for a high-risk population, such as
infants and toddlers born prematurely, is 1.33 to 2.5 times higher (Litchenstein & Ireton,
1984).
 Analysis of MDS and BSID-II Data
 To be considered valid, the MDS, like other screening procedures, must have
acceptable levels of sensitivity and specificity. The sensitivity of the MDS refers to the
instrument’s ability to identify correctly those children who are determined, through more
in-depth assessment, to have significant (>25%) developmental delays, and who will
ultimately require early intervention services.  The specificity of the MDS refers to the
test’s ability to identify those children who are neither significantly delayed (<25%) nor
in need of early intervention services.  As with any other screening instrument’s
sensitivity and specificity rates, an increased level in either rate will result in a risk of a
decreased level in the other.  In other words, an instrument that is highly sensitive may
over-identify children; all appropriate referrals for in-depth assessment may be made but
children who are not delayed may be incorrectly identified, thus subjecting them to
unnecessary assessment.  Conversely, if an instrument is highly specific, while children
not in need of in-depth assessment will not be subjected to testing, the risk is great that
children who are developmentally delayed may not be identified.
 The decision whether to use an instrument which is more sensitive or specific is
dependent on several factors.  According to Lichtenstein and Ireton (1984), a common
guideline is that it is more grave for an instrument to be less sensitive as this may lead to
under-referral to needed early intervention services. Local priorities and policies,
however, often drive the decisions whether to use a more sensitive or specific instrument.
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Furthermore, the emotional, clinical, and financial costs in coping with classification
errors of under- and over-referral must be considered.
 It was desirable for the MDS to err on the side of increased sensitivity rather than
specificity so that all children who are potentially eligible for early intervention services
receive them in an appropriate manner. Families routinely attend the NICU Follow-Up
Clinic in order for their child to receive medical and developmental follow-up related to
their prematurity.  Clinicians attend the clinic and receive payment for their time
regardless of the number of children seen.  Although children who receive false positive
results on the MDS will be subjected to timely in-depth assessments, often the
assessments occur on the same day as the screening or at the next routine appointment,
therefore there minimizing time constraints for the parents.  Furthermore, in an effort to
make the clinic experience optimally family-focused, the clinic’s coordinator informs
families of the potential of any screening instrument to over-identify children at risk.
To determine the sensitivity and specificity rates of the MDS the hit-rate model
was utilized.  Results of the MDS and the BSID-II were examined to determine the rate at
which the MDS correctly referred children to receive the BSID-II, the in-depth
assessment.  As illustrated in Table 5, each subject’s score on the MDS was recorded as
falling into one of the four following screening categories:
A. Accurate Referral/True Positive - results of MDS and BSID-II both indicated
developmental delay
B. Under-Referral/False Negative – results of MDS indicated no delay; BSID-II
indicated delay
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C. Over-Referral/False Positive – results of MDS indicated delay; BSID-II
indicated no delay
D. Accurate Non-referral/True Negative – results of both the MDS and BSID-II
indicated no delay
 Table 5
 MDS Screening Outcome Categories
 MDS  BSID-II
  Developmental Delay
(>25%)
 (+)
 
 No Developmental Delay
(<25%)
 (-)
 Refer
 Fail
 (+)
 A
 Accurate Referral/
 True Positive
 
 C
 Over-Referral/
 False Positive
 
 Do not refer
 Pass/Suspect
 (-)
 B
 Under-Referral/
 False Negative
 
 D
 Accurate Non-referral/
 True Negative
 
 Adapted from Lichtenstien & Ireton (1984)
 
 The rate of sensitivity (A/A+B) of the MDS was calculated by dividing the
number of accurate referrals (true positives) by the number of accurate referrals plus the
rate of under-referrals (false negatives).  The specificity rate (D/C+D) was calculated by
dividing the number of accurate non-referrals (true negatives) by the rate of over-referrals
(false positives) plus the number of accurate non-referrals. The overall hit rate (A+D/N)
was determined by dividing the number of accurate referrals (true positives and true
negatives) by the total sample.  The chance hit rate (p2 + q2) was established by
examining the prevelance (p) of the condition, defined as all children who were identified
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as delayed by the BSID-II (true positives and false positives) and the rate of the condition
in the population (q = 1-p).  Establishing the hit rate patterns of the MDS (i.e., whether
there is higher sensitivity or specificity, etc.) will provide evidence to help programs
decide if use of this screening tool is compatible with their objectives and goals.
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Chapter IV
Results
The study was designed to determine the validity of the Maryland Developmental
Screen (MDS) when concurrently administered with the Bayley Scales of Infant
Development, Second Edition (BSID-II) as measured through indices including
sensitivity, specificity, overall hit rate and chance hit rate.  Specifically the research
questions were:
1. What is the sensitivity of the MDS when concurrently administered with the
BSID-II?
2. What is the specificity of the MDS when concurrently administered with the
BSID-II?
3. What is the overall hit rate and chance hit rate of the MDS when compared to
the BSID-II?
The two measures were independently administered to a sample of infants and toddlers
born prematurely.  In addition, relevant demographic information regarding the subject
and family was obtained.  The study was conducted on Wednesdays at the University of
Maryland Medical System’s (UMMS) NICU Follow-Up Clinic for approximately nine
months (2/18/04-11/3/04).
A total of 103 families were approached to participate in this study. Thirteen
families did not wish to participate and provided the following reasons: time constraint
(n = 5), work schedule (n = 1), commute/traffic (n = 1), expiring parking meter (n = 1),
child too tired or upset (n = 4), or caregiver’s health (n = 1).  Of the 90 families agreeing
to participate, testing was not completed on seven children as two fell asleep and five
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were unable to complete testing due to lack of cooperation (e.g., crying). Two additional
subjects were excluded from the study as one child was born at full term (and not preterm
as required by inclusion criteria) and the other was not tested at the correct age.  The final
sample for this validation study included 81 children and their families. The sample was
stratified to represent the NICU Follow-Up Clinic’s visit schedule: 3, 6, 9, 12, 18, 24, 30,
and 36 months of age.  Caregivers of subjects were sequentially approached and recruited
as to meet the needs of the stratification (See Table 6).
Table 6
Stratification of Sample by NICU Follow-Up Clinic Visit Month
Visit N Percent
3 month 10 12.3%
6 month 9 11.1%
9 month 13 16.0%
12 month 10 12.3%
18 month 10 12.3%
24 month 9 11.1%
30 month 11 13.6%
36 month 9 11.1%
Total 81 100.0%
Demographic Information
Demographic information was collected with the Demographic Questionnaire (see
Appendix C) via chart review and orally administered questions.  Following completion
of consent procedures, parents were asked to respond to the questionnaire while in the
examination room either prior to or following test administration.  The researcher also
reviewed the child’s chart to gain NICU diagnoses and other relevant early intervention
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information.  The following infant characteristics and family characteristics were
examined.
Infant characteristics. The sample included (55.6%) male and (44.4%) female
infants and toddlers. The subjects were predominately African American (66.7%), with
the following ethnicities races reported: Caucasian (28.4%), Hispanic (1.2%), Bi-Racial
(2.5%), and Other (1.2%).  The gestational ages of the sample ranged from 23 weeks to
35 weeks gestation with a mean of 29 weeks gestation and a standard deviation of 2.63.
Ten percent of the sample were twins. The birth weights of the sample ranged from 542
grams to 2,634 grams, with a mean birth weight of 1,198 grams and a standard deviation
of 390.36.  Additional information regarding the breakdown of the sample’s gestational
ages and birth weights is provided in Table 7.  The children’s ages ranged from 4 months
of age through 37 months of age. When adjustments for prematurity were made
according to the NICU Follow-Up Clinic protocol, adjusted ages ranged from 18 days
through 37 months of age.
Table 7
Infant Characteristics (N = 81)
Gestational Age N Percent
of
Sample
Birth weight N Percent
of
Sample
23-26 weeks
27-30 weeks
31-35 weeks
21%
41%
28%
Extremely Low Birth
Weight (<1000 g.)
Very Low Birth weight
(>1001g <1500 g.)
Low birth weight
(> 1501g. <2500 g.)
24
40
17
30%
49%
21%
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The sample’s NICU history was examined to determine frequency of other
conditions related to high probability of developmental delay (see Table 8).  As
illustrated in Table 5, NICU histories included the following diagnoses: birth weight less
than 1,200 grams, bronchopulmonary dysplasia (BPD), patent ductus arterious (PDA),
necroitizing enterocolitis (NEC), intraventricular hemorrhagic infarctions (IVH) of Grade
III or Grade IV, drug withdrawal, hearing impairment, post hemorrhagic hydrocephalus,
and microcephaly.
Table 8
NICU Diagnoses Related to High Probability of Developmental Delay
NICU Diagnoses Percent of Sample
Birth weight less than 1,200 grams 51.9%
Bronchopulmonary dysplasia 24.1%
Patent ductus arterious 28.9%
Necrotizing enterocolitis 3.6%
Intreventricular hemorrahagic
infarctions (IVH) - Grade III or IV 3.6%
Drug exposure 2.4%
Hearing impairment 1.2%
Post hemmorhagic hydrocephalus 4.8%
Microcephaly 1.2%
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NICU Follow-Up Clinic and early intervention services.  Eighty-four percent of
the sample attended the NICU Follow-Up Clinic on the day of the study for a screening
appointment with neonatology; the remaining 16% were scheduled for a developmental
appointment with developmental pediatrics.  At the time of testing, 41 subjects (50.6%)
were enrolled in the Maryland Infants and Toddlers program.  These subjects were
receiving the following services: physical therapy (28.3%, n = 23), occupational therapy
(14.8%, n = 12), speech and language therapy (14.8%, n = 12), and special instruction
(7.4%, n = 6).
Family characteristics.  Most of subjects (59.3%) were accompanied to their
routine neonatology or developmental pediatrics NICU Follow-Up appointment by their
mother or jointly by their mother and father (27.2%). The majority of caregivers (50.6%)
were single; 42% were married, 4.9% were separated or divorced, and 1.2% reported that
they were together but not married (1.2% omitted this information).  The mothers’ mean
age was 28.95 years old and the fathers’ mean age was 33.74 years old (see Table 9). The
parents reported their education in a range from less than high school through Ph.D.
Many of the mothers and fathers reported their highest level of education to be a high
school degree or GED (33.3% and 32.1%, respectively), with a median level for the
mothers at some college and for the fathers at high school.
Geographically, these families resided in 11 of Maryland’s 24 counties
representative of five Maryland regions: 92.6% resided in Greater Baltimore (consisting
of urban, suburban, and rural areas, including Baltimore City), 4.7% lived in the Capital
Region (urban and suburban areas), 1.2% lived in Southern Maryland (a rural area), and
2.5% lived in the Eastern Shore (a rural area).  Baltimore City, the location of the NICU
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Follow-Up Clinic, was the most heavily represented area, reported by 49.4% of the
sample.
Table 9
Family Demographics
Demographics N % Median Mean Range SD
Mother’s Ages
     14-19
     20-29
     30-39
     40-53
     Information omitted
5
38
32
5
1
6.1%
46.7%
39.3%
6.1%
1.2%
29 years 28.95 (14-53) 7.24
Father’s Ages
    18-19
    20-29
    30-39
    40-49
    50-61
    Information Omitted
1
13
31
6
2
28
1.2%
16.1%
38.3%
7.4%
2.4%
34.6%
28 years 33.74 (18-63) 8.06
Mother’s Education
    Less than high school
    High School/GED
    Some College
    Associates Degree
    Bachelor’s Degree
    Master’s/Law Degree
    Ph.D., MD or similar
    Information omitted
10
27
21
8
9
3
1
2
12.3%
33.3%
25.9%
9.9%
11.1%
3.7%
1.2%
2.5%
Some
College N/A N/A N/A
Father’s Education
    Less than high school
    High school/GED
    Some College
    Associate’s/Vocational
    Bachelor’s
    Master’s/Law Degree
    Information omitted
1
26
6
2
10
5
28
1.2%
32.1%
7.4%
18.5%
12.3%
6.1%
34.6%
High
School N/A N/A N/A
Family Income
    < $10,000
    $10,000 -  $20,000
    $20,000 -  $30,000
    $30,000 - $40,000
    $40,000 - $50,000
    >$50,0000
    Information omitted
14
9
10
3
10
26
9
17.3%
11.1%
12.3%
3.7%
12.3%
32.1%
11.1%
$25,000 -
$30,000 N/A N/A N/A
N/A = not applicable
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Validity of the MDS
The goal of the present study was to explore the validity of the MDS when
concurrently administered with the BSID-II by examining the instrument’s sensitivity,
specificity, overall hit rate, and chance hit rate.  Following the completion of consent
procedures, children were concurrently administered the MDS and BSID-II.  The hit rate
model was the descriptive method for determining the validity of the MDS.  As
previously described in greater detail in Chapter III, this type of analysis examines the
outcome of a screening measure compared to a child’s actual status in terms of sensitivity
and specificity, overall hit rate, and chance hit rate.  As illustrated in Table 10, the
possible outcomes considered were 1) true negative, 2) true positive, 3) false positive,
and 4) false negative.  A total of 71.6% of the MDS results were classified as true
negative; these children passed the MDS and did not demonstrate a developmental delay
on the BSID-II.  The true positive outcomes of MDS, i.e., the children who failed the
MDS and also demonstrated a developmental delay on the BSDI-II, was 18.5%. The false
negative percentage was 2.5%; these children passed the MDS but their true
developmental status as measured by the BSID-II was greater than 25% delayed.  These
children represent an error of underprediction of developmental delays. The false
positives accounted for 7.4% of the total sample.  These children, representing the errors
of overprediction of developmental delay, failed according to overall MDS results but
their performance on the BSID-II suggests that they were less than 25% developmental
delayed.
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Table 10
MDS Screening Outcomes
Criterion (BSID-II)
Identified as
Delayed (>25%)
(+)
Not Identified as
Delayed (<25%)
(-)
Fail
Screen
(+)
A
True Positive
18.5%
(n = 15)
C
False Positive
28.6%
 (n = 6)
25.93%
(n = 21)
Screen
(MDS) Pass
Screen
(-)
B
False Negative
2.5%
(2)
D
True Negative
71.6%
(58)
74.07%
(n = 60)
21.90%
(n = 17)
79.0%
(n = 64)
100%
(n = 81)
 Sensitivity and Specificity
According to the American Academy of Pediatrics (2001), good developmental
screening tests should demonstrate sensitivity and specificity levels of at least 70% and
80% respectively. They report that complexity of assessing the continuous process of
child development contributes to the overdetection or underdetection of developmental
delays.  One of the research questions in this study was asked to determine the concurrent
validity of the MDS when compared to the results of the BSID-II when administered to a
sample of infants and toddlers born prematurely.  The sensitivity, or the percentage of
children correctly detected with the MDS as having a developmental delay, was 88.2%.
A second research question was asked to determine the specificity of the MDS when
concurrently compared to the BSID-II results when administered to a sample of infants
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and toddlers born prematurely.  The specificity of children correctly who passed the MDS
screening due to the absence of a developmental delay was 90.6%.  These rates suggest
that the MDS is a valid instrument when used to screen developmental status when used
with infants and toddlers born prematurely.
Overall and Chance Hit Rates
The final research question sought to determine the overall and chance hit rates of
the MDS with the BSID-II when the measures were concurrently administered to a
sample of infants and toddlers born prematurely.  The overall hit rate, defined as the
proportion of accurate screening decisions out of the total number of decisions, was
90.1% (n = 73). This indicates that 90.1% of the 81 MDS administrations yielded a true
positive or true negative outcome in terms of the child’s actual status. Further exploration
of this overall hit rate was necessary because, according to Speece and Cooper (2004),
overall hit rates may be “deceptively high when the prevalence of an adverse outcome is
low” (p.85).   It was therefore important to clarify the rate of subjects who were classified
as true negative or true positive on the MDS by chance alone rather than through true
classification.  This chance hit rate was important because there was an extremely large
number of true negatives, or children who passed MDS and passed BSID-II, and
therefore a disproportionate large number of hits. The chance hit rate (p2 + q2, where p =
prevalence of condition and q = rate of condition in population) for this sample was
determined to be 66.7%.  The overall hit rate of 90.1% of the sample population was
substantially greater than this chance hit rate.  A conclusion that may be drawn is that this
23.4% difference represents an improvement over chance that the MDS will correctly
identify children as either in need or not in need of an in-depth evaluation.
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Post Hoc Analysis
To eliminate the possibility that SES and other demographic variables contributed
to the results, a post hoc analysis was conducted to determine the levels of sensitivity and
specificity based upon age of the child, as well as across income levels and race (see
Appendix D for Hit Rates).  Although the findings of good sensitivity and specificity for
the total sample of 81 subjects demonstrated the validity of this instrument with a
population of infants and toddlers born prematurely, the decrease in the sample size when
various subgroups were analyzed led to some instability of results.  Table 11 presents the
findings.
Age-based sensitivity and specificity of the MDS.  When the age of the child was
collapsed into three categories based on year of life, the specificity of the MDS remained
high; 100% at year one, 83% at year two, and 82% at year three.  In this study, however,
the low sensitivity rate at year one, 33%, may have been detrimentally influenced by the
small number of results (n = 3) used for the calculation of this rate. There is a strong
indication of instability of the results due to the low number of subjects in this subgroup
classified as true positive or false negative test.  This indicates a need for more research
with larger sample sizes.
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Table 11
 Post Hoc Sensitivity and Specificity
Status N Percent
of Total
Sample
Sensitivity Specificity
Total Population 81 100% 88.2% 90.6%
Subject Age Visits
Year 1 (3, 6, & 9 month visits)
Year 2 (12, 18, & 24 month visits)
Year 3 (30 & 36 months )
32
29
20
41%
37%
25%
33%
100%
100%
100%
83%
82%
Yearly Household Income
Information not provided
Less than $25,000
$25,000 - $50,000
Greater than $50,000
9
27
19
26
11%
33%
23%
31%
100%
89%
75%
100%
71%
95%
93%
92%
Ethnicity
African American
Caucasian
Hispanic
Other
Bi-Racial
54
23
1
1
2
67%
23%
1%
1%
2%
92%
75%
*
*
*
95%
89%
*
*
*
Mother’s Education
Information not provided
Less than high school
High school/GED/vocational
Some college – Associate’s
Bachelor’s or higher
2
10
27
29
13
4%
12%
33%
36%
16%
100%
33%
100%
100%
100%
100%
100%
85%
92%
92%
Father’s Education
Information not provided
Less than high school
High school/GED/vocational
Some college – Associate’s
Bachelor’s or higher
28
1
26
11
15
35%
1%
32%
14%
19%
90%
*
67%
100%
100%
94%
*
91%
90%
85%
* Insufficient data
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Income-based sensitivity and specificity of the MDS. The sensitivity and
specificity levels were additionally examined across income levels to determine if a
person’s SES impacted the validity of test results.  Thirty-three percent of the subjects’
families reported a combined annual income level of less than $25,000.  The sensitivity
and specificity for this group remained high at 89% and 95% respectively.  Of the 23% of
families who reported their income to be between $25,000 and $50,000, the sensitivity
and specificity was 75% and 93%.  Although the sensitivity level in this group decreased,
it remained greater than the recommended level of 70% (American Academy of
Pediatrics, 2001).  Finally, 31% of the sample reported a combined family income of
greater than $50,000; sensitivity for this group was determined to be 100% and
specificity was 92%.  Eleven percent of the total sample did not provide information
regarding their income status. These finding suggest that the MDS may have validity
when administered to infants and toddlers born prematurely across all income groups, but
caution again should be taken in interpretation due to the small number in subjects in
each income subgroup.
Race-based Sensitivity and Specificity. The majority of the sample population
(67%) was African American and Caucasian (28%). Sensitivity and specificity were
calculated for these two groups only, as the other reported race categories did not have
enough subjects to conduct analysis (Hispanic n = 1, Other n = 1, Bi-racial n = 2).  The
sensitivity and specificity levels again remained high across the two race groups.  The
African American sample had levels of 92% sensitivity and 95% specificity and the
Caucasian group demonstrated sensitivity and specificity levels of 75% and 89%.
85
Education-based sensitivity and specificity. The subjects’ mothers’ and fathers’
education level was also examined to determine any notable trends.  Educational
categories were collapsed to analyze the following groups: (a) less than high school, (b)
high school or GED, (c) associate’s degree, some college, or vocational training, and (d)
bachelor’s degree or higher (including master’s degree, law degree, and Ph.D. degree).
Similar to the age category of year one, within the categories of mother’s education less
than high school and father’s education high school or GED, the number of true positives
and false negatives were notably low; the total number of subjects in each of these two
categories was three.  It was noteworthy, however, that the sensitivity for both the
mothers and fathers in each group was 100% for the two highest levels of education
classification (some college/associate’s degree/vocational training and bachelor’s degree
or higher).
An unexpected finding of this study was the relationship between the false
negative (pass MDS/fail BSID-II) and false positive outcomes (fail MDS/pass BSID-II)
in relation to developmental domain and age of the child.  Post Hoc analysis, including an
additional chart review, was conducted to explore these relationships.
False Negative Screening Outcomes
The false negative rate, referring to the children who received a pass on the MDS
but demonstrated a delay that was 25% or greater on the BSID-II, was 2.5% (n = 2).  It
was particularly important to investigate possible explanations for these results because
these subjects represented children whose developmental needs could be neglected due to
the lack of detection of a possible delay.  Both children were tested at the 3-month visit.
Difficulties in the gross motor domain were the prevalent concern for each child tested
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(see Table 12).   The first subject passed the MDS yet demonstrated an atypical gross
motor quality. Further investigation of this subject’s NICU Follow-Up record indicated
that the ultimate need for early intervention services matched the developmental status
determined with the BSID-II. The child was referred for a physical therapy assessment
from the NICU Follow-Up Clinic staff (due to atypical quality of performance) and
subsequently received physical therapy services. Although the second subject performed
at a greater than 25% delay on the BSID-II, upon examination of test items many failed
items were not appropriate for a child who is unable to sit at four months of age.
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Table 12
False Negative Screening Outcomes: Pass MDS/Fail BSID-II
BSID-IIAge
Tested
 MDS Quality
MDI MDI
Status
MDI
Age
PDI PDI Status PDI
Age
Notes Services
2m. Atypical gross
motor
54 Significant
delay
<1 m. 63 Significant
Delay
<1 m. 2 Standard deviations from
the norm and 25% delayed
Physical
therapy
4m. Typical 93 Mild delay 4 m. 83 Within
Normal
Limits
3 m. 25% delayed on PDI
Unable to sit to complete
many PDI gross motor items
(not appropriate at 4 m.)
None
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False Positive Screening Outcomes
The false positive rate, i.e., the percentage of subjects who failed the MDS but
were classified with a less than 25% delay on the BSID- II, was 28.6% (see Table 13).
Unlike the children with false negative MDS scores, whose adjusted ages ranged from
approximately two months old to four months old, the children with false positive scores
were older and ranged between 19 months to 34 months of age.  Rather than the gross
motor domain, the prevalent fail and suspect scores were found in the language domain
(fail = 4, suspect = 1). Although for purposes of analysis in this study the BSID-II results
were classified as less than 25% delay and greater or equal to 25% delay, the actual
BSID-II classification categories of within normal limits, mild delay, and significant
delay were examined to determine any relationship with the MDS scores.  Of the subjects
who failed the MDS, four were classified with a mild delay and one was classified with a
significant delay on either or both the MDI (n = 4) or the PDI (n = 2) of the BSID-II.
Only one subject failed the MDS and was within normal limits on both the MDI and PDI.
The subject in this case was 31 months and demonstrated a scatter of skills down to 22
months of age; clinical judgment of the researcher indicated that a speech and language
deficit was not captured utilizing the BSID-II.
Further analysis was then conducted to determine the early intervention outcome
for the children whose screening demonstrated false negative results.  Of the four
children who failed the language domain and the one failing the cognitive domain of the
MDS and passed the BSID-II, four ultimately received speech and language services as
recommended by the clinicians at the NICU Follow-Up Clinic.  One of the three children
who failed the gross motor domain of the MDS also subsequently received physical
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therapy services. These results suggest that the over-identification of language issues may
not be as problematic as it first appears.  The increased number of test items in an in-
depth evaluation should be designed for a child who does not do well on a screening that,
by the nature of a screening instrument, should have a limited number of test items.
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Table 13
False Positive Screening Outcomes: Fail MDS/Pass BSID-II
Age BSID-II Items Failed ServicesFailed MDS
Quality      Domain MDI MDI
Status
MDI
Age
PDI PDI Status PDI
Age
19 m. Typical Cognitive 75 Mild
delay
16 m. 90 Within
Normal
Limits
17 m. MDS: Look for ball, point to 4
body parts
None
25 m. Typical Language 70 Mild
delay
20 m. 76 Mild Delay 22 m. MDS: Two step command,
variegated jargon
MDS & BSID-II: Build train
with 2 cubes
Occupational
therapy
 Speech & language
therapy
27 m. Typical Language
Gross
motor
88 Within
normal
limits
25 m. 69 Significant
delay
22 < 25% Delay
MDS:  Engage pretend play,
MDS & BSID-II:  Repeat
number sequence, use word
sentences, jump up, up steps
alternating feet
Speech & language
therapy
Physical therapy
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Table 13 Continued: False Positive Screening Outcomes: Fail MDS/Pass BSID-II
BSID-IIAge Failed MDS
Quality      Domain MDI MDI
Status
MDI
Age
PDI PDI
Status
PDI
Age
Items Failed Services
31 m. Atypical Gross
motor
79 Mild
delay
25 m. 90 Within
Normal
Limit
27 m. MDS & BSID-II: Name six
pictures, up steps alternating
feet, stops making time
MDS: Pronouns
Inaccurate* BSID-II: Atypical
gross motor quality not
captured
Occupational
therapy
Physical therapy
Speech & language
therapy
31 m. Typical Language
Gross
motor
81 Mild
delay
26 m. 91 Within
Normal
Limits
28 m. MDS & BSID-II:
Prepositions, go up stairs
alternating feet
MDS: Name objects by use,
pronouns
Speech & language
therapy
34 m. Typical Language 77 Within
normal
limits
27 m. 112 WNL 37 m. Inaccurate*  BSID-II – speech
delay not captured
MDI scatter to 22 m.
None
* Inaccurate = administrator’s clinical impression
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Children Less Than One Month Corrected
Two subjects, based on an age equivalent score of less than one month,
demonstrated a delay of greater than 25% on the BSID-II.  When their status, however,
was based upon their BSID-II developmental score, one was classified as within normal
limits (MDI = 93) and the other as mild delay (PDI = 84). The adjusted age at which
these subjects were tested indicated that they were at the bottom limit of the testable age.
There was no rule in the BSID-II manual regarding how to address this situation.  The
following rule was made: if the subject’s BSID-II age equivalent was less than one month
and the developmental score was less than two standard deviations from the norm (within
normal limits or mild delay) a subject was considered to be not delayed. MDI and PDI
scores for all subjects are provided in Table
Atypical Development
Atypical development is a criterion that qualifies a child to receive Part C early
intervention services in Maryland, yet no published screening tool was found to be able
to identify this quality of development.  In Maryland, COMAR defines atypical
development or behavior as when “an abnormal quality of performance and function in at
least one of the five developmental areas interferes with current development, and is
likely to result in future developmental delay”
(http://www.dsd.state.md.us/comar/10/10.09.40.01.htm). The unique quality of the
performance component of the MDS enables administrators to score a child’s
development as atypical so that qualities that necessitate consultation with an appropriate
specialist may occur.  The atypical or typical decision made by the administrator is based
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upon their professional impression using guidelines that are presented in the MDS
manual.
Fourteen subjects were classified with an atypical quality of development on the
MDS.  Nine of these 14 subjects demonstrated a delay of less than 25% as measured by
the BSID-II; seven passed the screen with either an overall score of pass or suspect and
one failed the screen (see Table 14).  An additional chart review indicated that seven of
these subjects received subsequent early intervention services. The six children who
demonstrated an atypical quality on the MDS and demonstrated a 25% or greater delay
on the BSID-II were already receiving early intervention services. This suggests that the
MDS may have the ability to identify children who are in need of in-depth evaluation and
eligible for early intervention services due to atypical development concerns that would
otherwise be missed because of failure to consider the importance of the quality of child’s
performance.
Table 14
Atypical MDS Scores and Subsequent Early Intervention Services
BSID-II
< 25%
Delay
Received
early
intervention
services
BSID-II
> 25% Delay
Received
early
intervention
services
Pass/
Atypical
3 1 1 1MDS
Overall
Score
Suspect/
Atypical
4 4 0 0
Fail/Atypical 1 1 5 5
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CHAPTER V
Discussion
The intent of this study was to explore the concurrent validity of the Maryland
Developmental Screen (MDS) by examining the instrument’s predictive relationship with
the Bayley Scales of Infant Development, Second Edition (BSID-II). To address this
issue the following three research questions were asked:
1. What is the sensitivity of the MDS when concurrently administered with the
BSID-II?
2. What is the specificity of the MDS when concurrently administered with the
BSID-II?
3. What is the overall hit rate and chance hit rate of the MDS when compared to
the BSID-II?
 These questions were explored by concurrently and independently administering the
MDS and the BSID-II to a sample of 81 infants and toddlers born prematurely.  Results
suggest that when used with children born prematurely, the MDS is a valid
developmental screening measure. A discussion of these results is presented in this
chapter.
A statement made to the President’s Commission on Excellence in Special
Education (2002) indicates that there is a lack of appropriate screening tools and that
good screening tools need to be developed and validated. Hess and colleagues (2004)
support this by arguing that there is a need for alternative screening tools which have
better predictive utility and are brief and cost effective.  An in-depth analysis of 12
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instruments suggested that there was no measure that adequately met the screening needs
of infants and toddlers born prematurely.  The instruments evaluated included Ages and
Stages Questionnaire (ASQ), Healthy Steps “Quick Check Sheets”, Behavioral
Assessment of Baby’s Emotional and Social Style (BABES), Child Development
Inventories (CDI), Early Intervention Developmental Profile (EIDP), Brigance Screen,
Brigance Infant Toddler Screen (BITS), Diagnostic Inventory for Screening Children
(DISC), Battelle Developmental Inventory Screening Test, Bayley Infant
Neurodevelopmental Screen (BINS), the Parent’s Evaluation of Developmental Status
(PEDS), and the Denver Developmental Screen-II.  Instruments that appeared to be
capable of effectively screening for developmental delays were evaluated for the
following criteria: (1) developmental screening of all six developmental domains, (2) use
of minimal materials, (3) ease and speed in administration, (4) ability to test young
infants with an adjusted age of less than term, (5) hands-on assessment, (6) parent
involvement in the assessment process, (7) professional evaluation of the quality of the
child’s performance, and (8) validity of the instrument. Of the 12 tools reviewed, none
met each and every criterion.  The Battelle and the Denver II come the closest to meeting
these screening criteria; however, the Battelle does not provide enough items at each age
interval (Ikle & Wittmer, 1995) and the Denver II’s specificity and sensitivity has been
challenged by many researchers (Committee on Children with Disabilities, 2001; Glascoe
et al., 1992).
Results from this study suggest that the MDS may be capable of providing public
health, pediatric, and early intervention communities with a new option for screening the
development of children born prematurely.  The MDS examines six developmental
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domains, uses minimal materials, is easy to administer, is designed to test young infants
with an adjusted age of less than term, provides hands-on assessment, encourages parent
involvement, provides professional evaluation of the quality of the child’s performance,
and this study demonstrates its concurrent validity. Despite the fact that the MDS tests
children whose age at testing is less than full term, the concurrent validity with children
whose adjusted age was less than 16 days old could not be measured because the BSID-II
does not have the capability to assess children this young.  Future validation of the MDS
needs to address the validity at this young age through concurrent testing with
appropriate instruments.  Unfortunately, no tool currently exists for assessing children
whose adjusted age at time of testing is less than term (40 weeks gestation). Also, the
criterion that a screening instrument should be quick to administer should be tested.  The
amount of time needed to administer the MDS was not recorded in this or any other
study.  Although it is clinically suggested that the MDS is a screening tool that can be
administered within ten minutes (personal communication with Hussey-Gardner, April
28, 2005), the timing should be empirically measured.
 The results of this study suggest that that the MDS is a screening measure which
correlates with a child’s classification status on the BSID-II, (i.e., less than 25% delayed
and greater than or equal to 25% delayed), which in turn relates to the child’s eligibility
for early intervention services. The sensitivity (referring to the percentage of subjects
correctly detected at screening as having a developmental delay) in this study was 88.2%.
The specificity, i.e., the percentage of subjects correctly undetected by the screening due
to the absence of a developmental delay, was 90.6%.  These numbers indicate that the
MDS is a valid screening measure of infants and toddlers born prematurely.  The
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sensitivity and specificity levels of the MDS that were determined in this study provide
preliminary evidence that this instrument demonstrates validity that exceeds many other
known screening measures.  For additional information refer to Table 2 in Chapter II. The
sensitivity of the MDS, 88.2%, exceeded the levels of sensitivity found in research that
examined the CDI (Shoemaker, et al., 1993; Montgomery, 1999), Denver II (Glascoe et
al., 1992), the Brigance (Glascoe, 2002), BITS (Glascoe, 2002) and the Battelle (Ikle &
Wittmer). The specificity, 90.1%, also exceeded validity findings in research conducted
on the following instruments: CDI (Montgomery, 1999), Denver II (Glascoe et al, 1992),
BITS (Glascoe, 2002); and Battelle (Glascoe & Bryne, 1993).  Shoemaker and
colleagues’ (1993) research on the CDI was the only study found to exceed the MDS’
specificity level with a report of a level of 92%.
It is important to include in a discussion of sensitivity and specificity levels the
consequential validity related to the impact that a screening instrument may have when
incorporated into programs.  A tool that is overly sensitive will detect a greater number of
children who should receive further in-depth evaluation to determine their actual
developmental status.  This over-referral may be financially costly and present personnel
problems for programs because children who are not delayed and not in need of services
may be unnecessarily evaluated. Children who are in need of services and who might
otherwise not be recognized as delayed, however, are more likely to be identified.  A
measure that is more specific will most likely lead a more appropriate number of children
being referred for in-depth evaluation and therefore will be more cost-effective for a
program.  The major caveat to this approach, however, is that a tool that is excessively
specific may fail to identify children whose actual classification status is delayed,
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potentially leading to a postponement or omission of needed early intervention services.
It is the opinion of this researcher that it is more desirable for a screening tool to err on
the side of increased sensitivity, as does the MDS, so that all children who are potentially
eligible for early intervention services receive them in an appropriate and timely manner.
The prevalence rate, i.e., the percentage of children in the sample who were
identified as delayed based on the BSID-II, for this study was 28.6%. The prevalence rate
in the general population ranges from 5-10% (Litchenstein & Ireton, 1984); the rate in
this study, as expected, was higher.   The literature indicates that 33% of children born at
a low birth weight may develop neurological problems (Nadeau, Boivin, Tessier,
Lefebvre, & Robaey, 2001). The prevalence of disabilities for children born at an
extremely low birth weight (less than 1000 grams) has been found to be higher, at rates
such as 49% (Vohr et al., 2000) and 47% (Whitfield, 1997). Researchers (Vohr et al.,
2000) have used BSID-II Mental Developmental Index (MDI) and Psychomotor
Developmental Index (PDI) scores to examine the developmental status of children at 18
and 22 months of age.  Others (Whitfield et al., 1997) have examined children at school
age using other age appropriate assessments. Neither of these studies used percentage of
delay to determine the subjects’ developmental status.  Although it is unknown, the lower
prevalence rate of a delay in the present study compared to other studies may be
attributed to the inclusion of children in the sample who were born at higher birth
weights.  Another possible explanation may be the classification method used in this
study, which was indicated by a 25 percent delay on the BSID-II as opposed to a
classification based on standard deviation from the norm used in other studies (Whitfield
et al., 1997; Vohr et al., 2000).  Also, the prevalence rate in this study was perhaps lower
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due to the fact that some problems are not identified until an older age when preacademic
and academic skills emerge (Whitfield et al., 1997).
According to Litchenstein and Ireton (1984), results from hit-rate analysis are
situation-specific.  The results from this particular study reflect a decision rule (cutoff
point) of a developmental delay of 25% or greater as indicated by the BSID-II.  This
criteria was selected for the study because it is the percentage of delay required in
Maryland and many other states for a child to be eligible for early intervention services.
(Shackelford, 2004).  It was important that empirical evidence gained from this study be
translated into practical utility and as the results of the study results may be applicable to
many states that follow the same eligibility guidelines as Maryland.   If this decision rule
were changed, however, the results and hit rate patterns would most likely vary.
 The MDS demonstrated a unique ability to identify children who were in need of
in-depth assessment based upon an atypical quality of performance of test items.  No
other published screening instrument was found to meet this criterion.  The
administrators at the UMMS NICU Follow-Up Clinic demonstrated reliability in their
professional evaluation of the identification of atypical quality of performance. In other
settings, however, administrators may not have the clinical ability to identify such
problems.  This is a potential weakness of the MDS and is currently being addressed in
Hussey-Gardner’s revision of the manual to include specific indicators of atypical
development.
Implications for Research
Prior to this concurrent validity study, the MDS had yet to be subjected to
validation procedures.  The results of this concurrent validity study provide preliminary
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evidence that the MDS is a valid developmental screening tool when administered to
infants and toddlers born prematurely.  Validity of the MDS, however, has by no means
been definitely established.  As with any instrument, multiple studies must be conducted
with different samples to establish validity and there is need to examine consequential
validity of this screening instrument relative to social consequences and social
implications of MDS use (Messick, 1995).
The consequential validity of the MDS related to the eligibility criteria for early
intervention that is obtained from standardized assessments, should be critically
examined.   The percentage of developmental delay that a child may demonstrate is often
based on assessments such as the BSID-II and is the criterion upon which the acquisition
of early intervention services in Maryland is based. Although the percentage of delay
varies among states, this is the number one method across the country for identifying
children who are eligible for early intervention services (Shackelford, 2004).  Many
assessment tools, however, including the BSID-II, determine a child’s developmental
status based upon a score’s standard deviation from the mean on a norm-referenced
instrument.  It is questionable whether an instrument that is designed to classify children
based on standard deviation scores may appropriately identify children based upon an age
equivalent score (i.e., percentage of delay).  The BDID-II manual cautions doing this,
indicating that deriving developmental ages from the raw scores on the MDI and PDI
may result in an age range and not a specific age (Bayley, 1993). For example, in this
study, four children failed the MDS and were less than 25% delayed on the BSID-II.  The
BSID-II classification status for these children, however, was inconsistent as they were
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considered to be mildly delayed (see Table 13 in Chapter IV). Although MDI and PDI
scores were not analyzed in this study, the subjects’ scores are provided in Appendix E. 
Although not used for this study, the BSID-II manual’s (Bayley, 1993)
classifications of within normal limits, mild delay, or significant delay (see appendix F)
provides important insight into the issue of eligibility determination for early
intervention. For example, if all children who were considered to be mildly delayed (one
standard deviation from the norm) qualified for services, more children would be
identified and this increase would be costly to programs. It is recommended that the use
of the MDS be examined to determine how a decision to classify children (mildly delayed
in this example) as eligible for early intervention services impacts the validity of the
screening.
When the sample was subjected to post hoc analysis for SES (by ethnicity, family
yearly income, and parents’ education) the levels of sensitivity and specificity remained
generally high. These results were questionable however, and are perhaps explained by
the small number of subjects used in calculations in each SES category  (e.g., mother’s
education less than high school, N = 3). The majority of the sample was African
American, which was consistent with the rate of prematurity by race within Maryland
(March of Dimes, 2005).  There were, however, no American Indian or Asian subjects,
and there was little representation of Hispanic children born prematurely.
 Replicating this study with a much increased sample size will provide more accurate
concurrent validity evidence related to the use of the MDS with infants and toddlers born
prematurely when accounting for various SES factors.
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Hussey-Gardner’s (2003) intent was to identify infants and toddlers whose
development may delayed; therefore, the research regarding the validity of the MDS
should also be extended beyond infants and toddlers born prematurely.  Examples of
populations with which this study could be replicated include full term and typically
developing children, and children who may be at risk for developmental delay (e.g., Early
Head Start population).  The MDS is designed so that it may be used in a variety of
environments and not only in a clinical setting; the validity should therefore be examined
when administered in settings including early childhood centers, at children’s homes, and
in community settings.
The present study concurrently investigated the outcome of the MDS compared to
a child’s actual status as determined by the criterion measure, the BSID-II.  The BSID-II
was selected as the criterion measure due to the general consensus that the BSID-II is the
“gold standard” in early childhood assessment (Sattler, 1992).  The BSID-II is currently
undergoing revision and the Bayley Scales of Infant Development, Third Edition, will be
available for use in the fall of 2005.  Depending on the modifications that have been
made to this assessment, replication of this study using the newer version of the
instrument will need to be conducted.  Neither the BSID-II nor any other tool that was
published at the time of the study has the ability the MDS does to test children at an age
less than full term as well as at the older ages represented by the MDS.  A future
investigation of the MDS should include a concurrent validity study that uses a criterion
measure that focuses on children whose age is less than 16 days. Unfortunately, to date,
there is no criterion measure to validate this age range. The BSID-II examines the
hierarchy of child development through the Psychomotor Development Index (PDI) and
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the Mental Development Index (MDI) and does not separate testing items into domains.
The BSID-II manual indicates that the cognitive, language, motor, and personal/social
domains are represented in the test items of the PDI and MDI.  There is no mention of the
adaptive domain but many tasks relative to this domain are found within the two indexes.
Although there were no false positive or false negative results in this study specific to the
adaptive domain, further research should be conducted.  The false positive and false
negative findings in this study were largely in the gross motor and language domains.  It
may therefore be important to examine each domain represented in the MDS more
closely by concurrently using assessments such as the Peabody Developmental Motor
Scales as the criterion measure to further investigate specific domains of development.
Implications for Practice
The importance and need for accurate developmental screening of infants and
toddlers is reflected in policies from the American Academy of Pediatrics (Committee on
Children with Disabilities, 2001), EPSDT, Early Head Start (45 CFR 1304.20), and Part
C of the Individuals with Disabilities Education Improvement Act of 2004.  Results from
this validation study demonstrate the ability of the MDS to meet this need with one high
risk population, children born prematurely, and may lead to a specific impact in
promoting the development of infants and young children through an assurance of quality
of care and appropriate follow-up services.
It is intended that this evidence-based research will ultimately be transformed into
practice through the commercial production of the MDS. Public health, pediatric and
early intervention communities will then be able to use the MDS when screening the
development of infants and toddlers born prematurely to promote quality of care through
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an assurance of appropriate referral to early intervention and follow-up services. Prior to
publication more research is needed to validate the psychometrics of the MDS. In
addition to concurrent validity, predictive validity is particularly important for screening
tests (McLean et al., 1996).  Predictive validity is related to the extent to which a
screening instrument predicts later a child’ development.  For example, it is unknown
whether the MDS that accurately predicts a child’s performance on the BSID-II at two
months of age will also predict the outcome of the BSID-II when the same child is 12
months of age.  It is recommended that longitudinal studies related to the predictive
validity of the MDS be conducted, including, perhaps, research on how the predictive
validity of the MDS is related to later acquisition and need of early intervention services.
An examination of construct validity of the MDS should also be considered
through convergent and discriminate validity testing via correlation with other screening
tests (e.g. Bayley Infant Screener).  Tests with good convergent validity demonstrate a
high positive correlation with tests that measure the same construct; whereas good
discriminate validity has low correlation with tests measuring different constructs
(McLean et al., 1996).  These types of validity tests would to determine how MDS test
items in the areas of development represented (i.e., gross motor, adaptive, etc.) are able to
differentiate and isolate different skills that measure a child’s development in each of the
six domains (McLean et al., 1996).  This type of validity may be difficult to measure,
however, as no other screening instrument currently meets all recommended criteria for
effective screening of infants and toddlers born prematurely.
Reliability studies that examine procedural and scoring reliability and test retest
of the MDS should additionally be considered.  The interrater reliability related to scoring
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the MDS that was completed prior to this study demonstrated a high correlation between
administrators with a small sample (n = 12).   Additional scoring reliability testing as
well as procedural reliability is necessary to determine the extent to which examiners are
able to follow the administrative procedures in the MDS manual and to examine the
accuracy of scoring (McLean et al., 1996).  It is particularly important to determine the
administrators’ accuracy of in identifying atypical development. Test-retest is also
important to determine the extent to which MDS scores of the same children remain
stable over time (McLean et al., 1996).
In Maryland, if percentage of delay, rather than standard deviation from the norm
continues to be the criterion for eligibility (in addition to atypical development), a matrix
approach based on a child’s age should be considered. According to Shackelford (2005),
some states have designed a matrix to differentiate the amount of delay based upon the
age of the child.  This approach differentiates the amount of delay needed to qualify for
early intervention services based on age of a child.  This is because, for example, a six-
month-old child with a 25% percent delay is considerably different than a 24-month-old
with the same percentage of delay (Shackelford, 2005).
Many states allow early intervention eligibility to be determined through a delay
based on either standard deviation from the norm or age equivalent, or a combination of
both.  It is therefore recommended that the validity of the MDS be studied as it relates to
qualification criteria other than the 25% delay used in this study (such as standard
deviation or other percentages of delay).  Additional research should be specifically
examine the MDS to explore its validity with the 25% delay criterion compared to other
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states criteria (e.g., 50% delay in Oklahoma, 30% delay in Illinois) to determine the
impact that different criteria might have on Maryland’s early intervention system.
Limitations
The lack of true randomization of the sample was due to the clinical environment
of the NICU Follow-up Clinic.  A sequential and stratified recruitment of available
subjects was conducted to ensure that the sample was representative of the clinic’s
population.  A pitfall of concurrent validity research is the threat to internal validity
resulting from the testing history.  In this specific study the measure administered first
(either the MDS or the BSID-II) may have impacted the subject’s performance of a
particular task.  For example, a child may not have been able to build a tower of cubes
during the administration of the first measure but exposure through testing may have
resulted in the child learning and succeeding in the task during the next measure.  Data
was not collected on the order in which the measures were administered; if replication of
this study is conducted, this should be considered.  Finally, the use of developmental age
equivalent scores rather than actual scores on the BSID-II is a potential limitation of this
study.  As previously discussed, a 25 percent delay, and not standard deviation as
intended with the BSID-II, is a criterion for eligibility for early intervention services in
Maryland.  This fact drove the decision to use the age equivalent scores.  This remains,
however, in the opinion of this research, that this was the best way to do this study
because the 25% criterion is currently the number one way that eligibility is determined
throughout the country, not just in Maryland.
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Summary
The MDS is quick and easy to administer, uses minimal materials, uses hands-on
assessment, evaluates the quality of performance, tests all six developmental domains,
tests children at an age less than term, and uses parent report.  This concurrent validation
study demonstrates that the instrument has both strong sensitivity (88.2%) and specificity
(90.6%).  The low chance hit rate (66.68%) indicated that the high overall hit rate
(90.1%) was not due to chance alone. This information provides evidence that the MDS,
when used with infants and toddlers born prematurely, may be a valid method of
screening development.  The validity of the MDS should continue to be tested,
particularly if the instrument is to be published and use is extended beyond a population
of infants and toddlers born prematurely.
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Maryland Developmental Screen Name:____________________________________     DOB:_____/_____/_____
© 2003 University of Maryland, Baltimore
Developed by Brenda Hussey-Gardner, PhD, MPH Gestational Age:_____weeks          Birth Weight:__________grams
Scree
n Age DATE COGNITIVE LANGUAGE
SOCIAL-EMOTIONAL ADAPTIVE GROSS MOTOR FINE MOTOR ESULTS
Rooting present ORAN Flexion in legs during rest ORAN30-32
Week
s PCA
Eye opening
in dim light ORAN
Exhibits stress to
loud noises ORAN
Limited alertness for eye
contact ORAN Rhythmical
nonnutritive suck ORAN
Active flexion of legs
when alert ORAN
Active flexion of
arms when alert ORAN
P S F - T A
Y  N
Turns head from midline
to side ORAN32-36
Week
s PCA
Brief focus
on object ORAN
Responds to sound
inconsistently ORAN
Capacity for gentle
social interaction ORAN Begins to nipple feed ORAN Resistance to passive
movements legs ORAN
Resistance to
passive movements
arms ORAN
P S F - T A
Y  N
Flexed posture ORAN36-40
Week
s PCA
Blinks to light ORAN Responds to soundwith consistency ORAN Gazes at face ORAN Nipple feeds almost all ORAN
Stepping ORAN
Placing present ORAN P S F - T AY  N
Term Fixes on ring ORAN Cries ORAN Soothes when picked up ORAN Nipple feeds well ORAN Clears head in prone ORAN Palmar present ORAN P S F - T AY  N
1 Tracks ring30o ORAN Throaty noises ORAN Quiets to voice/face ORAN
Can maintain
alertness 1hr ORAN Head up in prone ORAN Hands fisted ORAN
P S F - T A
Y  N
2
Tracks ring
horizontally &
vertically
ORAN Single vowel sounds‘ooh, aah’ ORAN Social smile ORAN
Can sleep 3-4 hours at
night ORAN Chest up in prone ORAN Hands 50% unfisted ORAN
P S F - T A
Y  N
3 Tracks ring ina circle ORAN Coos when talked to ORAN Anticipatory excitement ORAN
Rooting reflex
inhibited ORAN
Forearm support in
prone ORAN
Reaches for objects,
misses ORAN
P S F - T A
Y  N
Laughs ORAN
4 Watches ownhands ORAN Turns head to voice ORAN
Vocalizes, smiles,
reaches more for
familiar people
ORAN Brings hands nearmouth ORAN Rolls supine to side ORAN Hands to midline ORAN
P S F - T A
Y  N
Secures ring ORAN Rolls prone to supine orsupine to prone ORAN5 Regards
Cheerio ORAN
Razz ORAN Strong maternalattachment ORAN Helps hold bottle ORAN Hand support in prone ORAN
Picks up cube ORAN
P S F - T A
Y  N
Says single syllables ORAN Sits tripod ORAN
6
Looks for
dropped
spoon
ORAN Holds arms out to be
picked up ORAN
Responds to own mirror
image ORAN
Swallows strained or
pureed foods ORAN Supports weight instanding ORAN
Raking ORAN
P S F - T A
Y  N
Crawls on belly ORAN Transfers ORAN
7 Pulls out peg ORAN Orients to bellupward/indirect ORAN Separation anxiety ORAN
Takes baby cereal &
baby foods well ORAN Sits without support ORAN Holds 1 cube &takes another ORAN
P S F - T A
Y  N
8 Rings bell ORAN Combines syllables ORAN Distinguishes own name ORAN Bites food voluntarily ORAN Creeps on all fours ORAN Thumb-finger grasp ORAN P S F - T AY  N
9 Removes lidfrom box ORAN
Imitates playful
sounds ORAN
Enjoys peek-a-boo
games ORAN
Holds, bites, chews
cracker ORAN Comes to sit ORAN Inferior pincer grasp ORAN
P S F - T A
Y  N
 Key:  Located on back.
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MARYLAND DEVELOPMENTAL SCREEN -- Page Two
Scree DATE COGNITIVE LANGUAGE SOCIAL-EMOTIONAL ADAPTIVE GROSS MOTOR FINE MOTOR ESULTS
Mature pincer grasp ORAN
10 Stirs inimitation ORAN
Dada/mama
appropriately ORAN
Responds with gesture
to nursery rhymes ORAN
Drinks from sippee
cup when held ORAN Pulls to stand ORAN Pokes holes ORAN
P S F - T A
Y  N
One word ORAN Cruises ORAN
11 Solves bearbehind cup ORAN
Waves bye-bye ORAN
Repeats performance if
laughed at ORAN
Finger feeds part of
meal ORAN
Stands alone ORAN
Puts cube in cup ORAN P S F - T AY  N
Two words ORAN Builds 2 cube tower ORAN
12 Spontaneousscribble ORAN 1-step command
with gesture ORAN
Gives toy on request ORAN
Drinks from cup with
sippee lid
independently
ORAN Walks with one handheld ORAN Overhand grasp ORAN
P S F - T A
Y  N
3 words ORAN
15
Looks for
‘Where is the
ball’
ORAN Points to indicate
wants ORAN
Wants to be near adults ORAN Takes off hat, shoes,socks ORAN
Walks quickly without
falling ORAN Puts 6 pegs in ORAN
P S F - T A
Y  N
7-9 words ORAN18 Points to 4body parts ORAN Points to 2 pictures ORAN Temper tantrums ORAN
Uses spoon with little
spilling ORAN Climbs into adult chair ORAN Puts 10 cubes in a cup ORAN
P S F - T A
Y  N
10-20 words ORAN Crawls up & down steps ORAN
21 Attends tostory ORAN Uses veregatedjargon ORAN
Parallel play ORAN Unzips zipper ORAN Runs ORAN Builds 3 cube tower ORAN
P S F - T A
Y  N
Follows 2-step
command ORAN Kicks ball forward ORAN24 4 cube train,no chimney ORAN 2-word sentences ORAN
Toys  ‘mine’ ORAN Wipes nose if given atissue ORAN Goes up steps marking
time ORAN
Turns pages of book
singly ORAN
P S F - T A
Y  N
Speech half
understandable ORAN27 Repeats 2digits ORAN Follows in/on ORAN
Engages in pretend
role- playing ORAN
Undresses with help
with buttons ORAN Jumps up ORAN
Imitates vertical &
horizontal strokes ORAN
P S F - T A
Y  N
Names 6 pictures ORAN Goes up stepsalternating feet ORAN
30
Names or
identifies
object by use
ORAN
Uses pronouns ORAN
Points to self in photo ORAN Dries hands ORAN
Walks on tip toes ORAN
Imitates circular hand
movements ORAN
P S F - T A
Y  N
Uses 3-word
sentences ORAN Dresses with help ORAN
33 Gives/shows1 ORAN Uses verb +ing ORAN
Has a friend ORAN
Toilet trained ORAN
Throws ball overhand ORAN Builds 9 cube tower ORAN P S F - T AY  N
250-word vocabulary ORAN Rides tricycle ORAN
36 Names 1color ORAN Uses prepositions ORAN Plays interactive games ORAN
Dresses
independently ORAN Balances on 1 foot 2seconds ORAN
Copies circle ORAN P S F - T AY  N
Answers yes/no ?s ORAN Broad jumps ORAN
39
Understands
top/bottom,
up/down
ORAN
Asks “wh” ?s ORAN
Expresses regret ORAN Washes hands ORAN
Goes down steps ORAN
Opens & closes lid ORAN P S F - T AY  N
KEY:  O = Observed, R = Reported, A = Atypical quality N = Neither observed nor reported. P = Pass: Child receives O or R for all items in age, re-screen at next visit, S = Suspect: Child receives N in one or more domains but
receives O or R for all items in that domain at preceding age range, re-screen at next visit, if two consecutive suspects refer to developmental team, F = Fail: Child receives N in current & preceding age range in one or more domains,
refer to developmental team. T = Typical quality of performance & no A’s marked in row, A = Atypical quality of performance with at least one item marked A in row, refer as needed. Y = Yes child’s performance was as parent
expected, N = No child’s performance was not as parent expected (+ indicates better than expected, -indicates not as good as expected).
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RESEARCH CONSENT FORM
The University of Maryland, College Park
The University of Maryland Medical Center
Title of Research Project: A Validation of the Maryland Developmental Screen
Principal Investigator: Brenda Hussey-Gardner, Ph.D., Division of Neonatology,
University of Maryland School of Medicine..  Phone:  410-328-8782
Co-Investigators:
Abigail McNinch, M.S., School of Education, UMCP Phone:  410-479-9565
Chris Reiner-Hess, Ph.D., Division of Neonatology, UMMS Phone: 410-247-8799
Explanation of Research Project to Subject:
PURPOSE OF STUDY
You and your child have been asked to participate in this research study because your
child was born prematurely and attends the NICU Follow-Up Clinic.  The purpose of this
study is to examine the validity of the Maryland Developmental Screen (MDS) to see if it
accurately identifies children whose development may be delayed and who would benefit
from more in-depth evaluation.
PROCEDURES
If you agree for your child to participate in this study you will first be asked to provide
the investigators with some demographic information about your child and your family
(e.g., child’s diagnosis, involvement in the early intervention system, caregiver’s
education level, etc.).  If your child is here today to see a neonatologist, he or she will be
assessed by the MDS as part of their routine NICU Follow-Up Clinic care.  Your child’s
development will also be tested using another assessment called the Bayley Scales of
Infant Development (BSID-II).  If your child has an appointment with the Developmental
Team, the MDS and the BSID-II will be given in addition to other scheduled
assessments.
Participation in this study will take approximately one hour.  It will be determined
randomly (like the flip of a coin) your child receives the MDS or the BSID-II first.  .
You will verbally receive results of all assessments conducted and a written report will be
provided if you request one.
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RISKS/DISCOMFORTS
There are no known risks or discomforts that may occur as a result of your child
participating in this study.
BENEFITS
You and your baby may benefit directly by participation in this study because you may
learn new information about your baby’s development.  The results of this study will also
help us determine how accurately the MDS assesses the developmental status of children.
COSTS/COMPENSATION
There is no cost or compensation if you agree to participate in this study.
CONFIDENTIALITY OF RECORDS
Any information learned from this study in which you might be identified will be
confidential and disclosed only with your permission.  If information learned from this
study is published, neither you nor your child will be identified by name.  Neither your
name, nor the name of your child will be associated with the data in any way, and all of
your data will be coded with a number for identification.  All data will be stored and
locked away in the office of the principal investigator, and only project personnel will
have access to the data.  By signing this form, however, you allow the research study
investigator to make your records available to the University of Maryland Medical
System (UMMS) and University of Maryland, College Park (UMCP) Institutional
Review Board (IRB) and regulatory agencies as required by law.  If information learned
from this study is published, you will not be identified by name.
RIGHT TO WITHDRAW
Participation in this study is voluntary.  You are not obligated to participate in this
research.  You are free to withdraw your consent at any time.  Refusal to participate will
not affect your current or future medical care in any way at the University of Maryland
Baltimore, University of Maryland Medical System. You will be told of any significant
new findings which develop during the study which may affect your willingness to
participate in this study.
OFFER TO ANSWER QUESTIONS AND RESEARCH INJURY NOTIFICATION
The principal investigator, Dr. Brenda Hussey-Gardner, or a colleague of Dr. Hussey-
Gardner responsible for this research study, has offered to answer any and all questions
regarding your participation in this research study.  If you have further questions or in the
event of a research related injury, you can contact Dr. Hussey-Gardner at the Department
of Neonatology, University of Maryland Medical System at 410-328-8782 or the IRB
offices of either UMMS (410-706-5037) or UMCP (310-405-4212).
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UNIVERSITY STATEMENT
The University of Maryland at Baltimore is committed to the safety of subjects
participating in research.  Our policies regarding possible risks are stated below.
RESPONSIBILITY FOR RESEARCH RELATED RISKS
Participating in research may result in an injury, as explained above.  If you suffer an
injury directly related to your participation in this project, the University of Maryland
Baltimore and/or one of its affiliated institutions or health care programs will help you
obtain medical treatment for the specific injury and provide referrals to other health care
facilities, as appropriate.  The University of Maryland Baltimore and/or its affiliated
institutions or health care groups will not provide you with financial compensation or
reimbursement for the cost of care provided to treat a research-related injury or for other
expenses arising from a research-related injury.  The institution or group providing
medical treatment will charge your insurance carrier, you, or any other party responsible
for your treatment costs.
MINIMAL RISK STUDIES
The University is committed to providing subjects of its research all rights due them
under State and federal law.  You give up none of your level rights by signing this
consent form or by participating in the research project.  Please call the Institutional
Review Board (IRB) if you have any questions about your rights as a research subject.
The research in this consent form has been classified as minimal risk by the University of
Maryland Institutional Review Board (IRB), a group of scientists, physicians, and other
experts.  The Board’s membership includes persons who are not affiliated with the
University and persons who do not conduct research projects.  The Board’s decision that
the research is minimal risk does not mean that the research is risk-free, however.
Generally speaking, you are assuming the risks of research participation, as discussed in
the consent form.  But, if you are harmed as a result of negligence of a research, you can
make a claim for compensation.  If you believe that you have been harmed through
participation in this research as a result of researcher negligence, you can contact the IRB
for more information about claims procedures.
YOUR RIGHTS IN THE EVENT OF STUDY-RELATED INJURY
By signing this Consent Form, you are not giving up any legal rights.  If this research
project is conducted in a negligent manner and you are injured as a direct result, you may
be able to recover the costs of care and other damages from the individual organizations
responsible for your injury.
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FURTHER INFORMATION AND CLAIMS PROCEDURES
Information regarding research may be obtained from the Institutional Review Board (a
group established to protect the rights of research subjects) at the following address
/telephone number.
Institutional Review Board
University of Maryland
685 West Baltimore Street
Baltimore, Maryland 21201
(410) 706-5037
If you have a study-related injury, you may contact the Institutional Review Board for
information about procedures for making claims against those who may be responsible
for injuries due to negligence.  In addition, the Institutional Review Board can provide
further information about the procedure to make claims for injures not related to
negligence.
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If you agree to join this study, please sign your name below.
NOT VALID WITHOUT THE IRB STAMP OF CERTIFICATION
___________________________________ ___________________
Caregiver’s Signature Date
____  I have read and understand the information on this form.
____ I have had the information on this form explained to me.
__________________________________ ____________________
Signature of Investigator Date
__________________________________ ____________________
Witness to Consent Procedures Date
(Optional unless subject is illiterate or
unable to sign
NOTE:  Copies of this Consent Form with original signature must be a) retained
on file by the  Principle Investigator; and b) given to the subject.  A copy must
also be deposited in the patient’s medical record.
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Validation of the Maryland Developmental Screen
DEMOGRAPHIC INFORMATION
1. Child’s Name: _________________________________
2. Sex: Male Female    
3. Date of Birth: ___/___/_____
4.      Gestational Age: ________  5.  Birth weight:  _________
6.   Child’s Race:
African American      Caucasian       Hispanic      Other_______________
7.    Caregiver(s) Present at Exam:
Mother                 Father                  Grandmother                    Grandfather                      Other
8.   Child’s Current diagnosis:
9.   County of Residence: ___________________________________
10.  Type of Childcare Arrangement (if any): ________________________
11. Child’s early intervention services:
Type Frequency  Location
  PT 1xwk    2xmo     1xmo     other Home Center
  OT 1xwk    2xmo     1xmo other Home Center
  SPL 1xwk    2xmo     1xmo other Home Center
  SI 1xwk    2xmo     1xmo other Home Center
  SC 1xwk    2xmo     1xmo other Home Center
Child’s Code #:
119
12. Parent’s marital status: Single Married Separated
13. Parent’s ages: Mother ______ Father ______
14. Parent’s highest level of education completed:
Mother Father
Less than 9th grade Less than 9th grade
           Some high school Some high school
GED GED
   High School High School
Some college Some college
AA Degree AA Degree
Bachelor’s degree Bachelor’s degree
Master’s degree Master’s degree
Ph.D., M.D. or similar degree Ph.D., M.D. or similar degree
15. Parent’s employment status and type of work:
________________________________________________________________________
________________________________________________________________________
16. Combine household yearly income:
Less than $10,000
Between $15,000 and $20,000
Between $20,000 and $25,000
Between $25,000 and $30,000
Between $30,000 and $40,000
Between $40,000 and $50,000
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HIT RATES
Age-Based Hit Rates
3, 6, 9 Months
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail(+)  1  0
 Pass/Suspect  (-)  2  29
Sensitivity = 33% Specificity = 100%
12, 18, & 24 Months
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  11  3
 Pass/Suspect (-)  0  15
Sensitivity = 100% Specificity = 83%
30 & 36 Months
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  3  3
 Pass/Suspect (-)  0  14
Sensitivity = 100% Specificity = 82%
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Ethnicity-Based Hit Rates
African American
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  12  3
 Pass/Suspect (-)  1  38
Sensitivity = 92% Specificity = 95%
Caucasian
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  3  2
 Pass/Suspect (-)  1  17
Sensitivity = 75% Specificity = 89%
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Combined Household Yearly Income
<$25,000
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  8  1
 Pass/Suspect (-)  1  17
Sensitivity = 89% Specificity = 95%
> $25,000 < $50,000
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  3  1
 Pass/Suspect (-)  1  14
Sensitivity = 75% Specificity = 93%
> $50,000
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  2  2
 Pass/Suspect (-)  0  22
Sensitivity = 100% Specificity = 92%
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Mother’s Education Hit Rates
< High School
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  1  0
 Pass/Suspect (-)  2  7
Sensitivity = 33% Specificity = 100%
High School/GED/Vocational
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  7  3
 Pass/Suspect (-)  0  17
Sensitivity = 100% Specificity = 85%
Some College/Associate’s Degree
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  5  2
 Pass/Suspect (-)  0  22
Sensitivity = 100% Specificity = 92%
> Bachelor’s Degree
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  1  1
 Pass/Suspect (-)  0  11
Sensitivity = 100% Specificity = 92%
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Father’s Education Hit Rates
< High School
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  0  0
 Pass/Suspect (-)  0  1
Insufficient cell sizes for sensitivity and specificity = %
High School/GED/Vocational
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  2  3
 Pass/Suspect (-)  1  23
Sensitivity = 67% Specificity = 91%
Some College/Associate’s Degree
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  1  0
 Pass/Suspect (-)  0  7
Sensitivity =100% Specificity = 90 %
> Bachelor’s Degree
 MDS  BSID-II
  >25% (+)  <25% (-)
 Fail (+)  2  2
 Pass/Suspect (-)  0  11
Sensitivity = 100% Specificity = 85%
126
APPENDIX E:
BSID-II MDI & PDI SCORES BY VISIT MONTH
127
Mental Developmental Index (MDI) Scores by Age Visit
Visit Month TotalMDI
3 6 9 12 18 24 30 36
<50 1 1
50 1 1 1 3
52 1 1
54 1 1
55 1 1
56 1 1
58 2 2
62 1 1 1 3
65 1 1
66 1 1
70 1 1 2
72 1 1
75 2 1 3
77 1 1 2
78 1 1
79 1 1
81 1 1
82 1 1
84 1 1 2 1 5
85 1 1 2
87 1 1
88 1 2 1 1 5
89 1 2 3
90 2 1 2 5
91 1 1
92 1 1 2
93 1 1
94 1 1
95 1 1
96 3 2 5
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MDI Scores by Age Visit, continued
MDI Visit Month Total
3 6 9 12 18 24 30 36
97 1 1
98 2 2 1 1 6
100 2 1 3
101 1 1
102 1 1
103 1 1 2
104 1 1
105 1 1
106 1 1
111 1 1
114 1 1
122 1 1
132 1 1
142 1 1
Total 10 9 13 10 10 9 11 9 81
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Psychomotor Developmental Index (PDI) Scores by Visit Month
Visit Month TotalPDI
3 6 9 12 18 24 30 36
45 1 1
50 1 1
52 1 1
55 1 1
57 1 1
59 1 1
63 1 1
66 1 1
67 1 1 2
69 1 1
72 1 1
76 2 1 3
77 1 1
78 1 1 2
79 1 1
80 1 1
81 1 1
83 1 1 2
84 1 1
85 1 2 3
87 1 1
88 1 1 2
89 1 2 3
90 1 2 1 4
91 1 2 1 4
92 2 2
93 1 1 2
94 1 2 1 1 5
95 1 1 1 3
96 1 1
97 1 1 1 3
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PDI Scores by Visit Month, continued
Visit Month TPDI
3 6 9 12 18 24 30 36
98 1 1
99 1 1
100 1 1 1 1 4
101 1 1
102 2 2
103 1 1
104 2 2
105 1 1 2
107 1 1
108 1 1 2
110 1 1
112 1 1
113 3 1 4
114 1 1
Total 10 9 13 10 10 9 11 9 81
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APPENDIX F:
BSID-II MDI & MPI CLASSIFICATION STATUS
132
BSID-II Classification for All Children
PDI Total
Within Normal
Limits
Mild Delay Significant
Delay
Within Normal
Limits
49 7 0 56
Mild Delay 7 3 0 10
Significant
Delay
6 3 6 15
MDI
Total 62 13 6 81
BSID-II Classification for Children Attending 3, 6, and 9 Month Visit
PDI Total
Within Normal
Limits
Mild Delay Significant
Delay
Within Normal
Limits
25 3 0 28
Mild Delay 1 1 0 2
Significant
Delay
0 1 1 2
MDI
Total 26 5 1 32
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BSID-II Classification for Children Attending 12, 18, and 24 Month Visit
PDI Total
Within Normal
Limits
Mild Delay Significant
Delay
Within Normal
Limits
13 2 0 15
Mild Delay 2 2 0 4
Significant
Delay
6 1 3 10
MDI
Total 21 5 3 29
BSID-II Classification for Children Attending 30 and 36 Month Visit
PDI Total
Within Normal
Limits
Mild Delay Significant
Delay
Within Normal
Limits
11 2 0 13
Mild Delay 4 0 0 4
Significant
Delay
0 1 2 3
MDI
Total 15 3 2 20
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